<html>
    <head>
        <meta charset="utf-8">
        
            <script src="lib/bindings/utils.js"></script>
            <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/dist/vis-network.min.css" integrity="sha512-WgxfT5LWjfszlPHXRmBWHkV2eceiWTOBvrKCNbdgDYTHrT2AeLCGbF4sZlZw3UMN3WtL0tGUoIAKsu8mllg/XA==" crossorigin="anonymous" referrerpolicy="no-referrer" />
            <script src="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/vis-network.min.js" integrity="sha512-LnvoEWDFrqGHlHmDD2101OrLcbsfkrzoSpvtSQtxK3RMnRV0eOkhhBN2dXHKRrUU8p2DGRTk35n4O8nWSVe1mQ==" crossorigin="anonymous" referrerpolicy="no-referrer"></script>
            
        
<center>
<h1></h1>
</center>

<!-- <link rel="stylesheet" href="../node_modules/vis/dist/vis.min.css" type="text/css" />
<script type="text/javascript" src="../node_modules/vis/dist/vis.js"> </script>-->
        <link
          href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/css/bootstrap.min.css"
          rel="stylesheet"
          integrity="sha384-eOJMYsd53ii+scO/bJGFsiCZc+5NDVN2yr8+0RDqr0Ql0h+rP48ckxlpbzKgwra6"
          crossorigin="anonymous"
        />
        <script
          src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/js/bootstrap.bundle.min.js"
          integrity="sha384-JEW9xMcG8R+pH31jmWH6WWP0WintQrMb4s7ZOdauHnUtxwoG2vI5DkLtS3qm9Ekf"
          crossorigin="anonymous"
        ></script>


        <center>
          <h1></h1>
        </center>
        <style type="text/css">

             #mynetwork {
                 width: 100%;
                 height: 600px;
                 background-color: #ffffff;
                 border: 1px solid lightgray;
                 position: relative;
                 float: left;
             }

             
             #loadingBar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width: 100%;
                 height: 600px;
                 background-color:rgba(200,200,200,0.8);
                 -webkit-transition: all 0.5s ease;
                 -moz-transition: all 0.5s ease;
                 -ms-transition: all 0.5s ease;
                 -o-transition: all 0.5s ease;
                 transition: all 0.5s ease;
                 opacity:1;
             }

             #bar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width:20px;
                 height:20px;
                 margin:auto auto auto auto;
                 border-radius:11px;
                 border:2px solid rgba(30,30,30,0.05);
                 background: rgb(0, 173, 246); /* Old browsers */
                 box-shadow: 2px 0px 4px rgba(0,0,0,0.4);
             }

             #border {
                 position:absolute;
                 top:10px;
                 left:10px;
                 width:500px;
                 height:23px;
                 margin:auto auto auto auto;
                 box-shadow: 0px 0px 4px rgba(0,0,0,0.2);
                 border-radius:10px;
             }

             #text {
                 position:absolute;
                 top:8px;
                 left:530px;
                 width:30px;
                 height:50px;
                 margin:auto auto auto auto;
                 font-size:22px;
                 color: #000000;
             }

             div.outerBorder {
                 position:relative;
                 top:400px;
                 width:600px;
                 height:44px;
                 margin:auto auto auto auto;
                 border:8px solid rgba(0,0,0,0.1);
                 background: rgb(252,252,252); /* Old browsers */
                 background: -moz-linear-gradient(top,  rgba(252,252,252,1) 0%, rgba(237,237,237,1) 100%); /* FF3.6+ */
                 background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,rgba(252,252,252,1)), color-stop(100%,rgba(237,237,237,1))); /* Chrome,Safari4+ */
                 background: -webkit-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Chrome10+,Safari5.1+ */
                 background: -o-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Opera 11.10+ */
                 background: -ms-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* IE10+ */
                 background: linear-gradient(to bottom,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* W3C */
                 filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#fcfcfc', endColorstr='#ededed',GradientType=0 ); /* IE6-9 */
                 border-radius:72px;
                 box-shadow: 0px 0px 10px rgba(0,0,0,0.2);
             }
             

             

             
        </style>
    </head>


    <body>
        <div class="card" style="width: 100%">
            
            
            <div id="mynetwork" class="card-body"></div>
        </div>

        
            <div id="loadingBar">
              <div class="outerBorder">
                <div id="text">0%</div>
                <div id="border">
                  <div id="bar"></div>
                </div>
              </div>
            </div>
        
        

        <script type="text/javascript">

              // initialize global variables.
              var edges;
              var nodes;
              var allNodes;
              var allEdges;
              var nodeColors;
              var originalNodes;
              var network;
              var container;
              var options, data;
              var filter = {
                  item : '',
                  property : '',
                  value : []
              };

              

              

              // This method is responsible for drawing the graph, returns the drawn network
              function drawGraph() {
                  var container = document.getElementById('mynetwork');

                  

                  // parsing and collecting nodes and edges from the python
                  nodes = new vis.DataSet([{"color": "#97c2fc", "description": "\"This is a collaborative organization involving multiple Chinese medical societies and associations focused on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD).\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u4e2d\u56fd\u89c6\u795e\u7ecf\u810a\u9ad3\u708e\u8c31\u7cfb\u75be\u75c5\u8bca\u65ad\u4e0e\u6cbb\u7597\u6307\u5357\u4e2d\u56fd\u514d\u75ab\u5b66\u4f1a\u795e\u7ecf\u514d\u75ab\u5b66\u5206\u4f1a \u4e2d\u534e\u533b\u5b66\u4f1a\u795e\u7ecf\u75c5\u5b66\u5206\u4f1a\u795e\u7ecf\u514d\u75ab\u5b66\u7ec4 \u4e2d\u56fd\u533b\u5e08\u534f\u4f1a\u795e\u7ecf\u5185\u79d1\u5206\u4f1a\u795e\u7ecf\u514d\u75ab\u4e13\u4e1a\u59d4\u5458\u4f1a\"", "label": "\"\u4e2d\u56fd\u89c6\u795e\u7ecf\u810a\u9ad3\u708e\u8c31\u7cfb\u75be\u75c5\u8bca\u65ad\u4e0e\u6cbb\u7597\u6307\u5357\u4e2d\u56fd\u514d\u75ab\u5b66\u4f1a\u795e\u7ecf\u514d\u75ab\u5b66\u5206\u4f1a \u4e2d\u534e\u533b\u5b66\u4f1a\u795e\u7ecf\u75c5\u5b66\u5206\u4f1a\u795e\u7ecf\u514d\u75ab\u5b66\u7ec4 \u4e2d\u56fd\u533b\u5e08\u534f\u4f1a\u795e\u7ecf\u5185\u79d1\u5206\u4f1a\u795e\u7ecf\u514d\u75ab\u4e13\u4e1a\u59d4\u5458\u4f1a\"", "shape": "dot", "size": 10, "source_id": "chunk-d3c46123897bf67b8ac7a319f7459d5e"}, {"color": "#97c2fc", "description": "\"NMOSD is a broader category of diseases that includes NMO and other related conditions, characterized by immune-mediated inflammatory demyelinating processes in the central nervous system (CNS).\"", "entity_type": "\"EVENT\"", "id": "\"\u89c6\u795e\u7ecf\u810a\u9ad3\u708e\u8c31\u7cfb\u75be\u75c5(NEUROMYELITIS OPTICA SPECTRUM DISORDERS, NMOSD)\"", "label": "\"\u89c6\u795e\u7ecf\u810a\u9ad3\u708e\u8c31\u7cfb\u75be\u75c5(NEUROMYELITIS OPTICA SPECTRUM DISORDERS, NMOSD)\"", "shape": "dot", "size": 10, "source_id": "chunk-d3c46123897bf67b8ac7a319f7459d5e"}, {"color": "#97c2fc", "description": "\"NMO is an immune-mediated inflammatory demyelinating disease primarily affecting the optic nerve and spinal cord, characterized by severe optic neuritis and longitudinally extensive transverse myelitis.\"", "entity_type": "\"EVENT\"", "id": "\"\u89c6\u795e\u7ecf\u810a\u9ad3\u708e(NEUROMYELITIS OPTICA, NMO)\"", "label": "\"\u89c6\u795e\u7ecf\u810a\u9ad3\u708e(NEUROMYELITIS OPTICA, NMO)\"", "shape": "dot", "size": 10, "source_id": "chunk-d3c46123897bf67b8ac7a319f7459d5e"}, {"color": "#97c2fc", "description": "\"AQP4-IgG is a highly specific antibody associated with NMOSD, which plays a crucial role in the pathogenesis and diagnosis of the disease.\"", "entity_type": "\"CONCEPT\"", "id": "\"AQP4-IGG (\u6c34\u901a\u9053\u86cb\u767d4\u6297\u4f53)\"", "label": "\"AQP4-IGG (\u6c34\u901a\u9053\u86cb\u767d4\u6297\u4f53)\"", "shape": "dot", "size": 10, "source_id": "chunk-d3c46123897bf67b8ac7a319f7459d5e"}, {"color": "#97c2fc", "description": "\"IPND is an international group that developed new diagnostic criteria for NMOSD, integrating NMO into the broader NMOSD category.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u56fd\u9645NMO\u8bca\u65ad\u5c0f\u7ec4(INTERNATIONAL PANEL ON NMO DIAGNOSIS, IPND)\"", "label": "\"\u56fd\u9645NMO\u8bca\u65ad\u5c0f\u7ec4(INTERNATIONAL PANEL ON NMO DIAGNOSIS, IPND)\"", "shape": "dot", "size": 10, "source_id": "chunk-d3c46123897bf67b8ac7a319f7459d5e"}, {"color": "#97c2fc", "description": "\"Wingerchuk and colleagues proposed the term NMOSD to encompass a broader range of related diseases in 2007.\"", "entity_type": "\"PERSON\"", "id": "\"WINGERCHUK\u7b49\"", "label": "\"WINGERCHUK\u7b49\"", "shape": "dot", "size": 10, "source_id": "chunk-d3c46123897bf67b8ac7a319f7459d5e"}, {"color": "#97c2fc", "description": "\"These are regions and ethnic groups where NMOSD is more prevalent compared to white populations.\"", "entity_type": "\"GEO\"", "id": "\"\u4e9a\u6d32\u3001\u62c9\u4e01\u7f8e\u6d32\u3001\u975e\u6d32\u3001\u897f\u73ed\u7259\u88d4\u548c\u7f8e\u56fd\u539f\u4f4f\u6c11\"", "label": "\"\u4e9a\u6d32\u3001\u62c9\u4e01\u7f8e\u6d32\u3001\u975e\u6d32\u3001\u897f\u73ed\u7259\u88d4\u548c\u7f8e\u56fd\u539f\u4f4f\u6c11\"", "shape": "dot", "size": 10, "source_id": "chunk-d3c46123897bf67b8ac7a319f7459d5e"}, {"color": "#97c2fc", "description": "\"These are autoimmune diseases that often co-occur with NMOSD, indicating a common underlying immune mechanism.\"", "entity_type": "\"EVENT\"", "id": "\"\u5e72\u71e5\u7efc\u5408\u5f81\u3001\u7cfb\u7edf\u6027\u7ea2\u6591\u72fc\u75ae\u3001\u6865\u672c\u6c0f\u75c5\"", "label": "\"\u5e72\u71e5\u7efc\u5408\u5f81\u3001\u7cfb\u7edf\u6027\u7ea2\u6591\u72fc\u75ae\u3001\u6865\u672c\u6c0f\u75c5\"", "shape": "dot", "size": 10, "source_id": "chunk-d3c46123897bf67b8ac7a319f7459d5e"}, {"color": "#97c2fc", "description": "\"NMOSD (Neuromyelitis Optica Spectrum Disorders) is a broader category of conditions that includes NMO and other related disorders. It has a wider clinical spectrum and includes non-opticospinal manifestations.\"\u003cSEP\u003e\"NMOSD (Neuromyelitis Optica Spectrum Disorders) is a group of autoimmune diseases characterized by high recurrence and high disability rates. It often co-occurs with other autoimmune diseases such as Sj\u00f6gren\u0027s syndrome, systemic lupus erythematosus, and Hashimoto\u0027s disease.\"\u003cSEP\u003e\"NMOSD (Neuromyelitis Optica Spectrum Disorders) is a group of autoimmune disorders characterized by inflammation of the optic nerve and spinal cord, with specific clinical and MRI features.\"\u003cSEP\u003e\"NMOSD (Neuromyelitis Optica Spectrum Disorders) \u662f\u4e00\u79cd\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\uff0c\u8868\u73b0\u4e3a\u591a\u79cd\u4e34\u5e8a\u75c7\u5019\u548c\u5f71\u50cf\u5b66\u7279\u5f81\u3002\"\u003cSEP\u003e\"NMOSD (Neuromyelitis Optica Spectrum Disorders) is a group of autoimmune disorders affecting the optic nerves and spinal cord, characterized by various visual and neurological symptoms.\"\u003cSEP\u003e\"NMOSD (Neuromyelitis Optica Spectrum Disorders) is a neurological condition characterized by inflammation of the optic nerves and spinal cord. The text discusses the treatment of NMOSD, including acute phase treatment, sequential treatment, symptomatic treatment, and rehabilitation.\"\u003cSEP\u003e\"NMOSD (Neuromyelitis Optica Spectrum Disorders) is a group of inflammatory disorders affecting the optic nerve and spinal cord.\"\u003cSEP\u003e\"NMOSD (Neuromyelitis Optica Spectrum Disorders) is a neurological disease characterized by inflammation and demyelination of the optic nerves and spinal cord.\"\u003cSEP\u003e\"NMOSD\uff08Neuromyelitis Optica Spectrum Disorders\uff09\u662f\u4e00\u79cd\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\uff0c\u8868\u73b0\u4e3a\u795e\u7ecf\u529f\u80fd\u969c\u788d\u548c\u590d\u53d1\u3002\"\u003cSEP\u003e\"NMOSD (Neuromyelitis Optica Spectrum Disorders) \u662f\u4e00\u79cd\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\uff0c\u8868\u73b0\u4e3a\u53cd\u590d\u53d1\u4f5c\u548c\u795e\u7ecf\u529f\u80fd\u969c\u788d\u3002\u73af\u78f7\u9170\u80fa\u548c\u7c73\u6258\u84bd\u918c\u7b49\u836f\u7269\u7528\u4e8e\u6cbb\u7597NMOSD\u3002\"\u003cSEP\u003e\"NMOSD (Neuromyelitis Optica Spectrum Disorders) is a neurological condition characterized by recurrent attacks on the optic nerves and spinal cord, leading to vision loss and other symptoms.\"", "entity_type": "\"CONCEPT\"", "id": "\"NMOSD\"", "label": "\"NMOSD\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1\u003cSEP\u003echunk-1508a751986aeefee59f14762ad947b8\u003cSEP\u003echunk-d760189ca87cf4816e2d4c9aaa4ad24c\u003cSEP\u003echunk-d542d24224ab1496d411addcf36c956e\u003cSEP\u003echunk-c7e6004f5252810899e285bab15d921b\u003cSEP\u003echunk-64c89732b9f2941c9331e3813eeb9803\u003cSEP\u003echunk-4729f02f7104a27cc56e83a3aba8a1a4\u003cSEP\u003echunk-e50d60a84829b64d6b34c785f4f1153e\u003cSEP\u003echunk-b9071098864a619d35d144407f2b30d2\u003cSEP\u003echunk-8ac7464d1b9ccfb3319afbae828cc7e1\u003cSEP\u003echunk-61b576d65721d15b39a0c520f28e6ee6"}, {"color": "#97c2fc", "description": "\"Sj\u00f6gren\u0027s Syndrome is an autoimmune disease that often co-occurs with NMOSD, characterized by dry eyes and mouth.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"SJ\u00d6GREN\u0027S SYNDROME\"", "label": "\"SJ\u00d6GREN\u0027S SYNDROME\"", "shape": "dot", "size": 10, "source_id": "chunk-8ac7464d1b9ccfb3319afbae828cc7e1"}, {"color": "#97c2fc", "description": "\"Systemic Lupus Erythematosus is an autoimmune disease that often co-occurs with NMOSD, affecting multiple organs and systems.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"SYSTEMIC LUPUS ERYTHEMATOSUS\"", "label": "\"SYSTEMIC LUPUS ERYTHEMATOSUS\"", "shape": "dot", "size": 10, "source_id": "chunk-8ac7464d1b9ccfb3319afbae828cc7e1"}, {"color": "#97c2fc", "description": "\"Hashimoto\u0027s Disease is an autoimmune disease that often co-occurs with NMOSD, characterized by chronic inflammation of the thyroid gland.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"HASHIMOTO\u0027S DISEASE\"", "label": "\"HASHIMOTO\u0027S DISEASE\"", "shape": "dot", "size": 10, "source_id": "chunk-8ac7464d1b9ccfb3319afbae828cc7e1"}, {"color": "#97c2fc", "description": "\"Vision Impairment is a common outcome for NMOSD patients, often resulting from the disease\u0027s high recurrence and disability rates.\"", "entity_type": "\"EVENT\"", "id": "\"VISION IMPAIRMENT\"", "label": "\"VISION IMPAIRMENT\"", "shape": "dot", "size": 10, "source_id": "chunk-8ac7464d1b9ccfb3319afbae828cc7e1"}, {"color": "#97c2fc", "description": "\"Motor Function Impairment is a common outcome for NMOSD patients, often resulting from the disease\u0027s high recurrence and disability rates.\"", "entity_type": "\"EVENT\"", "id": "\"MOTOR FUNCTION IMPAIRMENT\"", "label": "\"MOTOR FUNCTION IMPAIRMENT\"", "shape": "dot", "size": 10, "source_id": "chunk-8ac7464d1b9ccfb3319afbae828cc7e1"}, {"color": "#97c2fc", "description": "\"NMOSD frequently leads to Urinary and Bowel Dysfunction due to its high recurrence and disability rates.\"", "entity_type": "\"UNKNOWN\"", "id": "\"URINARY AND BOWEL DYSFUNCTION\"", "label": "\"URINARY AND BOWEL DYSFUNCTION\"", "shape": "dot", "size": 10, "source_id": "chunk-8ac7464d1b9ccfb3319afbae828cc7e1"}, {"color": "#97c2fc", "description": "\"ON (Optic Neuritis) is a clinical syndrome where the optic nerve is inflamed, often a core clinical feature of NMOSD.\"", "entity_type": "\"EVENT\"", "id": "\"ON\"", "label": "\"ON\"", "shape": "dot", "size": 10, "source_id": "chunk-d542d24224ab1496d411addcf36c956e"}, {"color": "#97c2fc", "description": "\"\u6025\u6027\u810a\u9ad3\u708e (Acute Myelitis) is a clinical syndrome where the spinal cord is inflamed, often a core clinical feature of NMOSD.\"", "entity_type": "\"EVENT\"", "id": "\"\u6025\u6027\u810a\u9ad3\u708e\"", "label": "\"\u6025\u6027\u810a\u9ad3\u708e\"", "shape": "dot", "size": 10, "source_id": "chunk-d542d24224ab1496d411addcf36c956e"}, {"color": "#97c2fc", "description": "\"\u5ef6\u9ad3\u6700\u540e\u533a\u7efc\u5408\u5f81 (Medulla Oblongata Syndrome) is a clinical syndrome affecting the medulla oblongata, often a core clinical feature of NMOSD.\"\u003cSEP\u003e\"\u5ef6\u9ad3\u6700\u540e\u533a\u7efc\u5408\u5f81\u662fNMOSD\u7684\u4e00\u79cd\u8868\u73b0\u5f62\u5f0f\uff0c\u4e3b\u8981\u75c7\u72b6\u5305\u62ec\u987d\u56fa\u6027\u5443\u9006\u3001\u6076\u5fc3\u3001\u5455\u5410\u7b49\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u5ef6\u9ad3\u6700\u540e\u533a\u7efc\u5408\u5f81\"", "label": "\"\u5ef6\u9ad3\u6700\u540e\u533a\u7efc\u5408\u5f81\"", "shape": "dot", "size": 10, "source_id": "chunk-d542d24224ab1496d411addcf36c956e\u003cSEP\u003echunk-e50d60a84829b64d6b34c785f4f1153e"}, {"color": "#97c2fc", "description": "\"NMO (Neuromyelitis Optica) is a neurological condition characterized by inflammation of the optic nerves and spinal cord. It has been updated and expanded over the past century, especially with the discovery of AQP4-IgG.\"\u003cSEP\u003e\"NMO (Neuromyelitis Optica) is a specific form of NMOSD characterized by lesions primarily in the optic nerve and spinal cord, historically described by Devic and Gault.\"\u003cSEP\u003e\"NMO (Neuromyelitis Optica) is a specific type of NMOSD characterized by inflammation of the optic nerve and spinal cord.\"", "entity_type": "\"CONCEPT\"", "id": "\"NMO\"", "label": "\"NMO\"", "shape": "dot", "size": 10, "source_id": "chunk-d542d24224ab1496d411addcf36c956e\u003cSEP\u003echunk-3f25f31870a5e0c1064ecb45bba89ae1\u003cSEP\u003echunk-c7e6004f5252810899e285bab15d921b"}, {"color": "#97c2fc", "description": "\"r\u2010ON (Recurrent Optic Neuritis) is a form of ON where the optic nerve is repeatedly inflamed, a clinical feature of NMOSD.\"", "entity_type": "\"EVENT\"", "id": "\"R\u2010ON\"", "label": "\"R\u2010ON\"", "shape": "dot", "size": 10, "source_id": "chunk-d542d24224ab1496d411addcf36c956e"}, {"color": "#97c2fc", "description": "\"TM (Transverse Myelitis) is a clinical syndrome where the spinal cord is inflamed, often a core clinical feature of NMOSD.\"", "entity_type": "\"EVENT\"", "id": "\"TM\"", "label": "\"TM\"", "shape": "dot", "size": 10, "source_id": "chunk-d542d24224ab1496d411addcf36c956e"}, {"color": "#97c2fc", "description": "\"LETM (Longitudinal Extensive Transverse Myelitis) is a form of TM where the spinal cord is extensively and longitudinally inflamed, a clinical feature of NMOSD.\"", "entity_type": "\"EVENT\"", "id": "\"LETM\"", "label": "\"LETM\"", "shape": "dot", "size": 10, "source_id": "chunk-d542d24224ab1496d411addcf36c956e"}, {"color": "#97c2fc", "description": "\"r\u2010LETM (Recurrent Longitudinal Extensive Transverse Myelitis) is a form of LETM where the spinal cord is repeatedly and extensively inflamed, a clinical feature of NMOSD.\"", "entity_type": "\"EVENT\"", "id": "\"R\u2010LETM\"", "label": "\"R\u2010LETM\"", "shape": "dot", "size": 10, "source_id": "chunk-d542d24224ab1496d411addcf36c956e"}, {"color": "#97c2fc", "description": "\"\u4e2d\u56fd\u795e\u7ecf\u514d\u75ab\u5b66\u548c\u795e\u7ecf\u75c5\u5b66\u6742\u5fd7\u662f\u4e00\u672c\u5b66\u672f\u671f\u520a\uff0c\u53d1\u8868\u5173\u4e8e\u795e\u7ecf\u514d\u75ab\u5b66\u548c\u795e\u7ecf\u75c5\u5b66\u7684\u7814\u7a76\u548c\u4e34\u5e8a\u89c2\u5bdf\u3002\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u4e2d\u56fd\u795e\u7ecf\u514d\u75ab\u5b66\u548c\u795e\u7ecf\u75c5\u5b66\u6742\u5fd7\"", "label": "\"\u4e2d\u56fd\u795e\u7ecf\u514d\u75ab\u5b66\u548c\u795e\u7ecf\u75c5\u5b66\u6742\u5fd7\"", "shape": "dot", "size": 10, "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e"}, {"color": "#97c2fc", "description": "\"\u810a\u9ad3\u75c5\u53d8\u662fNMOSD\u7684\u4e00\u79cd\u8868\u73b0\u5f62\u5f0f\uff0c\u53ef\u80fd\u4e0e\u5ef6\u9ad3\u6700\u540e\u533a\u7efc\u5408\u5f81\u76f8\u8fde\u7eed\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u810a\u9ad3\u75c5\u53d8\"", "label": "\"\u810a\u9ad3\u75c5\u53d8\"", "shape": "dot", "size": 10, "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e"}, {"color": "#97c2fc", "description": "\"\u8111\u5e72\u53ca\u7b2c\u56db\u8111\u5ba4\u5468\u8fb9\u75c7\u5019\u662fNMOSD\u7684\u4e00\u79cd\u8868\u73b0\u5f62\u5f0f\uff0c\u4e3b\u8981\u75c7\u72b6\u5305\u62ec\u5934\u6655\u3001\u590d\u89c6\u3001\u5171\u6d4e\u5931\u8c03\u7b49\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u8111\u5e72\u53ca\u7b2c\u56db\u8111\u5ba4\u5468\u8fb9\u75c7\u5019\"", "label": "\"\u8111\u5e72\u53ca\u7b2c\u56db\u8111\u5ba4\u5468\u8fb9\u75c7\u5019\"", "shape": "dot", "size": 10, "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e"}, {"color": "#97c2fc", "description": "\"\u4e0b\u4e18\u8111\u75c7\u5019\u662fNMOSD\u7684\u4e00\u79cd\u8868\u73b0\u5f62\u5f0f\uff0c\u4e3b\u8981\u75c7\u72b6\u5305\u62ec\u56f0\u5026\u3001\u53d1\u4f5c\u6027\u7761\u75c5\u6837\u8868\u73b0\u3001\u987d\u56fa\u6027\u4f4e\u94a0\u8840\u75c7\u3001\u4f53\u6e29\u8c03\u8282\u969c\u788d\u7b49\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u4e0b\u4e18\u8111\u75c7\u5019\"", "label": "\"\u4e0b\u4e18\u8111\u75c7\u5019\"", "shape": "dot", "size": 10, "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e"}, {"color": "#97c2fc", "description": "\"\u5927\u8111\u534a\u7403\u767d\u8d28\u6216\u80fc\u80dd\u4f53\u75c7\u5019\u662fNMOSD\u7684\u4e00\u79cd\u8868\u73b0\u5f62\u5f0f\uff0c\u4e3b\u8981\u75c7\u72b6\u5305\u62ec\u6de1\u6f20\u3001\u53cd\u5e94\u8fdf\u7f13\u3001\u8ba4\u77e5\u6c34\u5e73\u4e0b\u964d\u3001\u5934\u75db\u7b49\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u5927\u8111\u534a\u7403\u767d\u8d28\u6216\u80fc\u80dd\u4f53\u75c7\u5019\"", "label": "\"\u5927\u8111\u534a\u7403\u767d\u8d28\u6216\u80fc\u80dd\u4f53\u75c7\u5019\"", "shape": "dot", "size": 10, "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e"}, {"color": "#97c2fc", "description": "\"AQP4\u2010IgG\u9633\u6027\u662f\u6307\u60a3\u8005\u4f53\u5185\u5b58\u5728AQP4\u2010IgG\u6297\u4f53\uff0c\u4e0eNMOSD\u7684\u67d0\u4e9b\u8868\u73b0\u5f62\u5f0f\u76f8\u5173\u3002\"", "entity_type": "\"EVENT\"", "id": "\"AQP4\u2010IGG\u9633\u6027\"", "label": "\"AQP4\u2010IGG\u9633\u6027\"", "shape": "dot", "size": 10, "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e"}, {"color": "#97c2fc", "description": "\"\u98ce\u6e7f\u76f8\u5173\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u662f\u4e00\u7c7b\u75be\u75c5\uff0c\u5305\u62ec\u5e72\u71e5\u7efc\u5408\u5f81\u3001\u7cfb\u7edf\u6027\u7ea2\u6591\u72fc\u75ae\u3001\u6865\u672c\u6c0f\u75c5\u7b49\uff0c\u53ef\u80fd\u4e0eNMOSD\u5408\u5e76\u5b58\u5728\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u98ce\u6e7f\u76f8\u5173\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\"", "label": "\"\u98ce\u6e7f\u76f8\u5173\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\"", "shape": "dot", "size": 10, "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e"}, {"color": "#97c2fc", "description": "\"ANA (\u6297\u6838\u6297\u4f53) \u662f\u4e00\u79cd\u81ea\u8eab\u514d\u75ab\u6027\u76f8\u5173\u6297\u4f53\uff0c\u53ef\u80fd\u4e0eNMOSD\u5408\u5e76\u5b58\u5728\u3002\"", "entity_type": "\"EVENT\"", "id": "\"ANA\"", "label": "\"ANA\"", "shape": "dot", "size": 10, "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e"}, {"color": "#97c2fc", "description": "\"SSA (\u6297SSA\u6297\u4f53) \u662f\u4e00\u79cd\u81ea\u8eab\u514d\u75ab\u6027\u76f8\u5173\u6297\u4f53\uff0c\u53ef\u80fd\u4e0eNMOSD\u5408\u5e76\u5b58\u5728\u3002\"", "entity_type": "\"EVENT\"", "id": "\"SSA\"", "label": "\"SSA\"", "shape": "dot", "size": 10, "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e"}, {"color": "#97c2fc", "description": "\"SSB (\u6297SSB\u6297\u4f53) \u662f\u4e00\u79cd\u81ea\u8eab\u514d\u75ab\u6027\u76f8\u5173\u6297\u4f53\uff0c\u53ef\u80fd\u4e0eNMOSD\u5408\u5e76\u5b58\u5728\u3002\"", "entity_type": "\"EVENT\"", "id": "\"SSB\"", "label": "\"SSB\"", "shape": "dot", "size": 10, "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e"}, {"color": "#97c2fc", "description": "\"\u8111\u810a\u6db2(CSF) \u662fNMOSD\u7684\u5b9e\u9a8c\u5ba4\u68c0\u67e5\u9879\u76ee\u4e4b\u4e00\uff0c\u7528\u4e8e\u8bc4\u4f30\u60a3\u8005\u7684\u708e\u75c7\u548c\u514d\u75ab\u53cd\u5e94\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u8111\u810a\u6db2(CSF)\"", "label": "\"\u8111\u810a\u6db2(CSF)\"", "shape": "dot", "size": 10, "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e"}, {"color": "#97c2fc", "description": "\"Wingerchuk is a researcher who, along with others, developed the 2006 NMO diagnostic criteria.\"", "entity_type": "\"PERSON\"", "id": "\"WINGERCHUK\"", "label": "\"WINGERCHUK\"", "shape": "dot", "size": 10, "source_id": "chunk-1508a751986aeefee59f14762ad947b8"}, {"color": "#97c2fc", "description": "\"The International NMO Diagnosis Panel (IPND) is a group of experts who developed the 2015 NMOSD diagnostic criteria.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"INTERNATIONAL NMO DIAGNOSIS PANEL (IPND)\"", "label": "\"INTERNATIONAL NMO DIAGNOSIS PANEL (IPND)\"", "shape": "dot", "size": 10, "source_id": "chunk-1508a751986aeefee59f14762ad947b8"}, {"color": "#97c2fc", "description": "\"AQP4-IgG is an antibody that has been identified as a biomarker for NMO and NMOSD, significantly advancing the understanding and diagnosis of these conditions.\"\u003cSEP\u003e\"AQP4-IgG is an autoantibody that is a key marker for diagnosing NMOSD, particularly in distinguishing between AQP4-IgG positive and negative cases.\"\u003cSEP\u003e\"AQP4-IgG\u662f\u4e00\u79cd\u6297\u4f53\uff0c\u7528\u4e8e\u8bca\u65adNMOSD\uff0c\u4f46\u4efb\u4f55\u5316\u9a8c\u68c0\u67e5\u90fd\u5b58\u5728\u4e00\u5b9a\u7684\u5047\u9633\u6027\u548c\u5047\u9634\u6027\u60c5\u51b5\u3002\"", "entity_type": "\"CONCEPT\"", "id": "\"AQP4-IGG\"", "label": "\"AQP4-IGG\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1\u003cSEP\u003echunk-1508a751986aeefee59f14762ad947b8\u003cSEP\u003echunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"MS (Multiple Sclerosis) is a different autoimmune disorder that affects the central nervous system, often requiring exclusion in NMOSD diagnosis.\"", "entity_type": "\"EVENT\"", "id": "\"MS (MULTIPLE SCLEROSIS)\"", "label": "\"MS (MULTIPLE SCLEROSIS)\"", "shape": "dot", "size": 10, "source_id": "chunk-1508a751986aeefee59f14762ad947b8"}, {"color": "#97c2fc", "description": "\"OCT is a diagnostic tool used to measure the thickness of the retinal nerve fiber layer, which is often affected in NMOSD patients.\"", "entity_type": "\"TECHNOLOGY\"", "id": "\"OCT (OPTICAL COHERENCE TOMOGRAPHY)\"", "label": "\"OCT (OPTICAL COHERENCE TOMOGRAPHY)\"", "shape": "dot", "size": 10, "source_id": "chunk-1508a751986aeefee59f14762ad947b8"}, {"color": "#97c2fc", "description": "\"Visual Evoked Potentials is a diagnostic test that measures the electrical activity in the visual pathways, often showing abnormalities in NMOSD patients.\"", "entity_type": "\"TECHNOLOGY\"", "id": "\"VISUAL EVOKED POTENTIALS\"", "label": "\"VISUAL EVOKED POTENTIALS\"", "shape": "dot", "size": 10, "source_id": "chunk-1508a751986aeefee59f14762ad947b8"}, {"color": "#97c2fc", "description": "\"MRI is a diagnostic imaging technique used to identify lesions in the spinal cord and brain, which are important for diagnosing NMOSD.\"", "entity_type": "\"TECHNOLOGY\"", "id": "\"MRI (MAGNETIC RESONANCE IMAGING)\"", "label": "\"MRI (MAGNETIC RESONANCE IMAGING)\"", "shape": "dot", "size": 10, "source_id": "chunk-1508a751986aeefee59f14762ad947b8"}, {"color": "#97c2fc", "description": "\"Corticosteroids, specifically methylprednisolone and prednisone, are used in the acute phase treatment of NMOSD to reduce inflammation and improve neurological function. The treatment involves high-dose intravenous administration followed by a gradual tapering to a maintenance dose.\"", "entity_type": "\"DRUG\"", "id": "\"\u7cd6\u76ae\u8d28\u6fc0\u7d20 (CORTICOSTEROIDS)\"", "label": "\"\u7cd6\u76ae\u8d28\u6fc0\u7d20 (CORTICOSTEROIDS)\"", "shape": "dot", "size": 10, "source_id": "chunk-d760189ca87cf4816e2d4c9aaa4ad24c"}, {"color": "#97c2fc", "description": "\"Methylprednisolone is a corticosteroid used in the acute phase treatment of NMOSD. It is administered intravenously in high doses to rapidly reduce inflammation and improve neurological function.\"", "entity_type": "\"DRUG\"", "id": "\"\u7532\u6cfc\u5c3c\u9f99 (METHYLPREDNISOLONE)\"", "label": "\"\u7532\u6cfc\u5c3c\u9f99 (METHYLPREDNISOLONE)\"", "shape": "dot", "size": 10, "source_id": "chunk-d760189ca87cf4816e2d4c9aaa4ad24c"}, {"color": "#97c2fc", "description": "\"Prednisone is a corticosteroid used in the maintenance phase of NMOSD treatment. It is administered orally in gradually decreasing doses to prevent relapse and manage long-term symptoms.\"\u003cSEP\u003e\"\u6cfc\u5c3c\u677e is a corticosteroid used in low doses to maintain treatment and reduce NMOSD recurrence, often in combination with immunosuppressants.\"", "entity_type": "\"DRUG\"", "id": "\"\u6cfc\u5c3c\u677e (PREDNISONE)\"", "label": "\"\u6cfc\u5c3c\u677e (PREDNISONE)\"", "shape": "dot", "size": 10, "source_id": "chunk-d760189ca87cf4816e2d4c9aaa4ad24c\u003cSEP\u003echunk-4729f02f7104a27cc56e83a3aba8a1a4"}, {"color": "#97c2fc", "description": "\"Plasma exchange (PE) is a treatment method used for NMOSD, particularly in patients who do not respond well to high-dose methylprednisolone.\"", "entity_type": "\"EVENT\"", "id": "\"\u8840\u6d46\u7f6e\u6362 (PE)\"", "label": "\"\u8840\u6d46\u7f6e\u6362 (PE)\"", "shape": "dot", "size": 10, "source_id": "chunk-c7e6004f5252810899e285bab15d921b"}, {"color": "#97c2fc", "description": "\"Intravenous immunoglobulin (IVIg) is a treatment method used for NMOSD, particularly in patients who do not respond well to high-dose methylprednisolone.\"", "entity_type": "\"EVENT\"", "id": "\"\u9759\u8109\u6ce8\u5c04\u5927\u5242\u91cf\u514d\u75ab\u7403\u86cb\u767d (IVIG)\"", "label": "\"\u9759\u8109\u6ce8\u5c04\u5927\u5242\u91cf\u514d\u75ab\u7403\u86cb\u767d (IVIG)\"", "shape": "dot", "size": 10, "source_id": "chunk-c7e6004f5252810899e285bab15d921b"}, {"color": "#97c2fc", "description": "\"\u73af\u78f7\u9170\u80fa is a second-line drug used in the treatment of NMOSD, particularly for patients who cannot undergo IVIg or PE treatment.\"\u003cSEP\u003e\"\u73af\u78f7\u9170\u80fa\u662f\u4e00\u79cd\u836f\u7269\uff0c\u7528\u4e8e\u51cf\u5c11NMOSD\u590d\u53d1\u548c\u51cf\u7f13\u795e\u7ecf\u529f\u80fd\u969c\u788d\u8fdb\u5c55\u3002\u5b83\u4f5c\u4e3a\u4e8c\u7ebf\u836f\u7269\uff0c\u9002\u7528\u4e8e\u5176\u4ed6\u6cbb\u7597\u65e0\u6548\u7684\u60c5\u51b5\u3002\u63a8\u8350\u7528\u6cd5\u5305\u62ec600mg\u9759\u8109\u6ef4\u6ce8\uff0c1\u6b21/2\u5468\uff0c\u8fde\u7eed5\u4e2a\u6708\uff1b600mg\u9759\u8109\u6ef4\u6ce8\uff0c\u6bcf\u4e2a\u67081\u6b21\uff0c\u517112\u4e2a\u6708\u3002\u5e74\u603b\u8d1f\u8377\u5242\u91cf\u4e0d\u8d85\u8fc710~15g\u3002\u4e3b\u8981\u526f\u4f5c\u7528\u5305\u62ec\u6076\u5fc3\u3001\u5455\u5410\u3001\u611f\u67d3\u3001\u8131\u53d1\u3001\u6027\u817a\u6291\u5236\u3001\u6708\u7ecf\u4e0d\u8c03\u3001\u505c\u7ecf\u548c\u51fa\u8840\u6027\u8180\u80f1\u708e\u3002\u9884\u9632\u51fa\u8840\u6027\u8180\u80f1\u708e\u53ef\u540c\u65f6\u5e94\u7528\u7f8e\u53f8\u94a0(Uromitexan)\u6ce8\u5c04\uff0c\u6076\u5fc3\u548c\u5455\u5410\u53ef\u9002\u5f53\u5e94\u7528\u6b62\u5410\u836f\u5bf9\u6297\u3002\"\u003cSEP\u003e\"\u73af\u78f7\u9170\u80fa\u4e0d\u63a8\u8350\u5728\u598a\u5a20\u524d\u671f\u3001\u598a\u5a20\u548c\u54fa\u4e73\u671f\u4f7f\u7528\uff0c\u5177\u6709C\u7ea7\u63a8\u8350\uff0c\u9664\u975e\u5b55\u5987\u5177\u6709\u751f\u547d\u5371\u9669\u6216\u5668\u5b98\u529f\u80fd\u8870\u7aed\u98ce\u9669\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u73af\u78f7\u9170\u80fa\"", "label": "\"\u73af\u78f7\u9170\u80fa\"", "shape": "dot", "size": 10, "source_id": "chunk-b9071098864a619d35d144407f2b30d2\u003cSEP\u003echunk-08e2af106947799f5d0790038b946347\u003cSEP\u003echunk-61b576d65721d15b39a0c520f28e6ee6"}, {"color": "#97c2fc", "description": "\"\u786b\u5511\u560c\u5464 is a first-line drug used in the treatment of NMOSD, effective in reducing recurrence and slowing the progression of neurological dysfunction.\"\u003cSEP\u003e\"\u786b\u5511\u560c\u5464\u662f\u4e00\u79cd\u836f\u7269\uff0c\u7528\u4e8e\u6cbb\u7597NMOSD\u3002\u5417\u66ff\u9ea6\u8003\u915a\u916f\u8d77\u6548\u8f83\u786b\u5511\u560c\u5464\u5feb\uff0c\u526f\u4f5c\u7528\u8f83\u5c11\u3002\"\u003cSEP\u003e\"\u786b\u5511\u560c\u5464\u63a8\u8350\u5728\u598a\u5a20\u671f\u4f7f\u7528\uff0c\u5242\u91cf\u9700\u22642mg/(kg\u30fbd)\uff0c\u5177\u6709B\u7ea7\u63a8\u8350\uff0c\u54fa\u4e73\u671f\u4f7f\u7528\u5177\u6709D\u7ea7\u63a8\u8350\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u786b\u5511\u560c\u5464\"", "label": "\"\u786b\u5511\u560c\u5464\"", "shape": "dot", "size": 10, "source_id": "chunk-b9071098864a619d35d144407f2b30d2\u003cSEP\u003echunk-08e2af106947799f5d0790038b946347\u003cSEP\u003echunk-64c89732b9f2941c9331e3813eeb9803"}, {"color": "#97c2fc", "description": "\"\u5417\u66ff\u9ea6\u8003\u915a\u916f is a first-line drug used in the treatment of NMOSD.\"\u003cSEP\u003e\"\u5417\u66ff\u9ea6\u8003\u915a\u916f\u662f\u4e00\u79cd\u836f\u7269\uff0c\u7528\u4e8e\u51cf\u5c11NMOSD\u7684\u590d\u53d1\u548c\u51cf\u7f13\u795e\u7ecf\u529f\u80fd\u969c\u788d\u8fdb\u5c55\u3002\u63a8\u8350\u7528\u6cd5\u4e3a1~1.5g/d\uff0c\u53e3\u670d\u3002\u5176\u526f\u4f5c\u7528\u8f83\u5c11\uff0c\u4e3b\u8981\u4e3a\u80c3\u80a0\u9053\u75c7\u72b6\u548c\u589e\u52a0\u611f\u67d3\u673a\u4f1a\u3002\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u5417\u66ff\u9ea6\u8003\u915a\u916f\"", "label": "\"\u5417\u66ff\u9ea6\u8003\u915a\u916f\"", "shape": "dot", "size": 10, "source_id": "chunk-b9071098864a619d35d144407f2b30d2\u003cSEP\u003echunk-64c89732b9f2941c9331e3813eeb9803"}, {"color": "#97c2fc", "description": "\"\u7532\u6c28\u8776\u5464 is a first-line drug used in the treatment of NMOSD.\"\u003cSEP\u003e\"\u7532\u6c28\u8776\u5464\u5728\u598a\u5a20\u671f\u5e94\u907f\u514d\u4f7f\u7528\uff0c\u53d7\u5b55\u524d3\u4e2a\u6708\u5e94\u505c\u7528\uff0c\u54fa\u4e73\u671f\u4e0d\u63a8\u8350\u4f7f\u7528\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u7532\u6c28\u8776\u5464\"", "label": "\"\u7532\u6c28\u8776\u5464\"", "shape": "dot", "size": 10, "source_id": "chunk-b9071098864a619d35d144407f2b30d2\u003cSEP\u003echunk-08e2af106947799f5d0790038b946347"}, {"color": "#97c2fc", "description": "\"\u5229\u59a5\u6614\u5355\u6297 (rituximab) is a first-line drug used in the treatment of NMOSD.\"", "entity_type": "\"DRUG\"", "id": "\"\u5229\u59a5\u6614\u5355\u6297 (RITUXIMAB)\"", "label": "\"\u5229\u59a5\u6614\u5355\u6297 (RITUXIMAB)\"", "shape": "dot", "size": 10, "source_id": "chunk-b9071098864a619d35d144407f2b30d2"}, {"color": "#97c2fc", "description": "\"\u4ed6\u514b\u83ab\u53f8 is a second-line drug used in the treatment of NMOSD.\"\u003cSEP\u003e\"\u4ed6\u514b\u83ab\u53f8\u63a8\u8350\u5728\u598a\u5a20\u671f\u4f7f\u7528\u6700\u4f4e\u6709\u6548\u5242\u91cf\uff0c\u5177\u6709D\u7ea7\u63a8\u8350\uff0c\u54fa\u4e73\u671f\u4f7f\u7528\u5177\u6709D\u7ea7\u63a8\u8350\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u4ed6\u514b\u83ab\u53f8\"", "label": "\"\u4ed6\u514b\u83ab\u53f8\"", "shape": "dot", "size": 10, "source_id": "chunk-b9071098864a619d35d144407f2b30d2\u003cSEP\u003echunk-08e2af106947799f5d0790038b946347"}, {"color": "#97c2fc", "description": "\"\u7c73\u6258\u84bd\u918c is a second-line drug used in the treatment of NMOSD.\"\u003cSEP\u003e\"\u7c73\u6258\u84bd\u918c\u662f\u4e00\u79cd\u836f\u7269\uff0c\u7528\u4e8e\u51cf\u5c11NMOSD\u590d\u53d1\u3002\u5b83\u4f5c\u4e3a\u4e8c\u7ebf\u836f\u7269\uff0c\u9002\u7528\u4e8e\u53cd\u590d\u53d1\u4f5c\u800c\u5176\u4ed6\u65b9\u6cd5\u6cbb\u7597\u6548\u679c\u4e0d\u4f73\u7684\u60c5\u51b5\u3002\u63a8\u8350\u7528\u6cd5\u5305\u62ec\u6309\u4f53\u8868\u9762\u79ef(10~12)mg/m2\u9759\u8109\u6ef4\u6ce8\uff0c\u6bcf\u4e2a\u67081\u6b21\uff0c\u51713\u4e2a\u6708\uff0c\u540e\u6bcf3\u4e2a\u67081\u6b21\u518d\u75283\u6b21\uff0c\u603b\u91cf\u4e0d\u8d85\u8fc7100mg/m2\u3002\u4e3b\u8981\u526f\u4f5c\u7528\u5305\u62ec\u5fc3\u810f\u6bd2\u6027\u548c\u6cbb\u7597\u76f8\u5173\u7684\u767d\u8840\u75c5\uff0c\u4f7f\u7528\u65f6\u5e94\u6ce8\u610f\u76d1\u6d4b\u5176\u5fc3\u810f\u6bd2\u6027\u3002\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u7c73\u6258\u84bd\u918c\"", "label": "\"\u7c73\u6258\u84bd\u918c\"", "shape": "dot", "size": 10, "source_id": "chunk-b9071098864a619d35d144407f2b30d2\u003cSEP\u003echunk-61b576d65721d15b39a0c520f28e6ee6"}, {"color": "#97c2fc", "description": "\"IVIg (Intravenous Immunoglobulin) is a treatment used in the prevention of NMOSD, particularly for patients who cannot use immunosuppressants.\"", "entity_type": "\"TREATMENT\"", "id": "\"IVIG\"", "label": "\"IVIG\"", "shape": "dot", "size": 10, "source_id": "chunk-b9071098864a619d35d144407f2b30d2"}, {"color": "#97c2fc", "description": "\"PE (Plasma Exchange) is a treatment used in the prevention of NMOSD, particularly for patients who cannot use immunosuppressants.\"", "entity_type": "\"TREATMENT\"", "id": "\"PE\"", "label": "\"PE\"", "shape": "dot", "size": 10, "source_id": "chunk-b9071098864a619d35d144407f2b30d2"}, {"color": "#97c2fc", "description": "\"AQP4\u2010IgG is a biomarker used to identify patients with NMOSD, particularly those who are positive for this marker.\"\u003cSEP\u003e\"AQP4\u2010IgG is a specific biomarker for Neuromyelitis Optica (NMO), with high specificity and sensitivity. It is detected using methods like CBA and ELISA.\"", "entity_type": "\"BIOMARKER\"", "id": "\"AQP4\u2010IGG\"", "label": "\"AQP4\u2010IGG\"", "shape": "dot", "size": 10, "source_id": "chunk-b9071098864a619d35d144407f2b30d2\u003cSEP\u003echunk-3ae28088c4f039d981f2d5100cb16987"}, {"color": "#97c2fc", "description": "\"\u5355\u65f6\u76f8\u53ca\u591a\u65f6\u76f8NMOSD refers to the different phases of NMOSD, with single-phase and multi-phase types.\"", "entity_type": "\"DISEASE_TYPE\"", "id": "\"\u5355\u65f6\u76f8\u53ca\u591a\u65f6\u76f8NMOSD\"", "label": "\"\u5355\u65f6\u76f8\u53ca\u591a\u65f6\u76f8NMOSD\"", "shape": "dot", "size": 10, "source_id": "chunk-b9071098864a619d35d144407f2b30d2"}, {"color": "#97c2fc", "description": "\"\u513f\u7ae5\u53ca\u598a\u5a20\u671f\u60a3\u8005 refers to a specific group of patients, including children and pregnant women, who may require special considerations in NMOSD treatment.\"", "entity_type": "\"PATIENT_GROUP\"", "id": "\"\u513f\u7ae5\u53ca\u598a\u5a20\u671f\u60a3\u8005\"", "label": "\"\u513f\u7ae5\u53ca\u598a\u5a20\u671f\u60a3\u8005\"", "shape": "dot", "size": 10, "source_id": "chunk-b9071098864a619d35d144407f2b30d2"}, {"color": "#97c2fc", "description": "\"\u5229\u59a5\u6614\u5355\u6297\u4e0d\u5efa\u8bae\u5728\u598a\u5a20\u524d\u671f\u3001\u598a\u5a20\u548c\u54fa\u4e73\u671f\u4f7f\u7528\uff0c\u56e0\u4e3a\u80ce\u513f\u7684\u5b89\u5168\u6027\u6587\u732e\u4e0d\u8db3\uff0c\u7406\u8bba\u4e0a\u5b58\u5728\u98ce\u9669\u3002\"\u003cSEP\u003e\"\u5229\u59a5\u6614\u5355\u6297\u662f\u4e00\u79cd\u9488\u5bf9B\u7ec6\u80de\u8868\u9762CD20\u7684\u5355\u514b\u9686\u6297\u4f53\uff0c\u7528\u4e8e\u51cf\u5c11NMOSD\u7684\u590d\u53d1\u548c\u51cf\u7f13\u795e\u7ecf\u529f\u80fd\u969c\u788d\u8fdb\u5c55\u3002\u63a8\u8350\u7528\u6cd5\u4e3a\u6309\u4f53\u8868\u9762\u79ef375mg/m2\u9759\u8109\u6ef4\u6ce8\uff0c\u6bcf\u54681\u6b21\uff0c\u8fde\u75284\u5468\uff1b\u62161000mg\u9759\u8109\u6ef4\u6ce8\uff0c\u5171\u75282\u6b21\uff08\u95f4\u96942\u5468\uff09\u3002\u56fd\u5185\u6cbb\u7597\u7ecf\u9a8c\u8868\u660e\uff0c\u4e2d\u7b49\u6216\u5c0f\u5242\u91cf\u5e94\u7528\u5bf9\u9884\u9632NMOSD\u4ecd\u6709\u6548\uff0c\u4e14\u526f\u53cd\u5e94\u5c0f\uff0c\u82b1\u8d39\u76f8\u5bf9\u8f83\u5c11\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u5229\u59a5\u6614\u5355\u6297\"", "label": "\"\u5229\u59a5\u6614\u5355\u6297\"", "shape": "dot", "size": 10, "source_id": "chunk-08e2af106947799f5d0790038b946347\u003cSEP\u003echunk-64c89732b9f2941c9331e3813eeb9803"}, {"color": "#97c2fc", "description": "\"\u6cfc\u5c3c\u677e is used in low doses to maintain treatment and reduce NMOSD recurrence, often in combination with other immunosuppressants.\"", "entity_type": "\"UNKNOWN\"", "id": "\"\u6cfc\u5c3c\u677e\"", "label": "\"\u6cfc\u5c3c\u677e\"", "shape": "dot", "size": 10, "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4"}, {"color": "#97c2fc", "description": "\"\u73af\u5b62\u7d20A is recommended at a specific dose to reduce NMOSD recurrence, with careful monitoring for renal toxicity.\"\u003cSEP\u003e\"\u73af\u5b62\u7d20A\u63a8\u8350\u5728\u598a\u5a20\u671f\u4f7f\u7528\u6700\u4f4e\u6709\u6548\u5242\u91cf\uff0c\u5177\u6709B\u7ea7\u63a8\u8350\uff0c\u54fa\u4e73\u671f\u4f7f\u7528\u5177\u6709D\u7ea7\u63a8\u8350\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u73af\u5b62\u7d20A\"", "label": "\"\u73af\u5b62\u7d20A\"", "shape": "dot", "size": 10, "source_id": "chunk-08e2af106947799f5d0790038b946347\u003cSEP\u003echunk-4729f02f7104a27cc56e83a3aba8a1a4"}, {"color": "#97c2fc", "description": "\"\u03b2 \u5e72\u6270\u7d20, a treatment for MS, can worsen NMOSD symptoms, highlighting the need for caution in its use.\"", "entity_type": "\"UNKNOWN\"", "id": "\"\u0392 \u5e72\u6270\u7d20\"", "label": "\"\u0392 \u5e72\u6270\u7d20\"", "shape": "dot", "size": 10, "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4"}, {"color": "#97c2fc", "description": "\"\u82ac\u6208\u83ab\u5fb7, a treatment for MS, can exacerbate NMOSD symptoms, emphasizing the need for careful selection of treatments.\"", "entity_type": "\"UNKNOWN\"", "id": "\"\u82ac\u6208\u83ab\u5fb7\"", "label": "\"\u82ac\u6208\u83ab\u5fb7\"", "shape": "dot", "size": 10, "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4"}, {"color": "#97c2fc", "description": "\"\u90a3\u4ed6\u73e0\u5355\u6297, a treatment for MS, can worsen NMOSD symptoms, underlining the importance of avoiding certain MS treatments in NMOSD patients.\"", "entity_type": "\"UNKNOWN\"", "id": "\"\u90a3\u4ed6\u73e0\u5355\u6297\"", "label": "\"\u90a3\u4ed6\u73e0\u5355\u6297\"", "shape": "dot", "size": 10, "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4"}, {"color": "#97c2fc", "description": "\"\u514d\u75ab\u6291\u5236\u5242 are used to reduce NMOSD recurrence but may have long-term risks such as increased susceptibility to infections and cancer, requiring careful consideration.\"", "entity_type": "\"UNKNOWN\"", "id": "\"\u514d\u75ab\u6291\u5236\u5242\"", "label": "\"\u514d\u75ab\u6291\u5236\u5242\"", "shape": "dot", "size": 10, "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4"}, {"color": "#97c2fc", "description": "\"NMOSD patients have a similar risk of recurrence during pregnancy as non-pregnant periods, but a higher risk postpartum, necessitating continued immunosuppressive treatment.\"", "entity_type": "\"UNKNOWN\"", "id": "\"\u598a\u5a20\u671f\"", "label": "\"\u598a\u5a20\u671f\"", "shape": "dot", "size": 10, "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4"}, {"color": "#97c2fc", "description": "\"\u5fb7\u7ef4\u514b (Devic) is a historical figure who, along with his student \u9ad8\u5c14\u7279 (Gault), described a group of cases with severe optic nerve and spinal cord involvement, leading to the naming of Devic\u0027s disease.\"", "entity_type": "\"PERSON\"", "id": "\"\u5fb7\u7ef4\u514b\"", "label": "\"\u5fb7\u7ef4\u514b\"", "shape": "dot", "size": 10, "source_id": "chunk-d542d24224ab1496d411addcf36c956e"}, {"color": "#97c2fc", "description": "\"\u9ad8\u5c14\u7279 (Gault) is a historical figure, a student of \u5fb7\u7ef4\u514b (Devic), who contributed to the description of cases with severe optic nerve and spinal cord involvement.\"", "entity_type": "\"PERSON\"", "id": "\"\u9ad8\u5c14\u7279\"", "label": "\"\u9ad8\u5c14\u7279\"", "shape": "dot", "size": 10, "source_id": "chunk-d542d24224ab1496d411addcf36c956e"}, {"color": "#97c2fc", "description": "\"Neuromyelitis Optica (NMO) is a neurological disorder characterized by inflammation and demyelination of the optic nerves and spinal cord.\"", "entity_type": "\"DISEASE\"", "id": "\"NEUROMYELITIS OPTICA (NMO)\"", "label": "\"NEUROMYELITIS OPTICA (NMO)\"", "shape": "dot", "size": 10, "source_id": "chunk-3ae28088c4f039d981f2d5100cb16987"}, {"color": "#97c2fc", "description": "\"CBA is a highly specific and sensitive method for detecting AQP4\u2010IgG, with a specificity of over 90% and sensitivity of 70%.\"", "entity_type": "\"TECHNOLOGY\"", "id": "\"CELL-BASED TRANSFECTION IMMUNOFLUORESCENCE ASSAY (CBA)\"", "label": "\"CELL-BASED TRANSFECTION IMMUNOFLUORESCENCE ASSAY (CBA)\"", "shape": "dot", "size": 10, "source_id": "chunk-3ae28088c4f039d981f2d5100cb16987"}, {"color": "#97c2fc", "description": "\"ELISA is a sensitive method for detecting AQP4\u2010IgG, but it can produce false positives and has some controversy regarding its use for predicting disease progression and recurrence.\"", "entity_type": "\"TECHNOLOGY\"", "id": "\"ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)\"", "label": "\"ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)\"", "shape": "dot", "size": 10, "source_id": "chunk-3ae28088c4f039d981f2d5100cb16987"}, {"color": "#97c2fc", "description": "\"ANAs are autoantibodies that can be present in the serum of patients with NMOSD, supporting the diagnosis.\"", "entity_type": "\"CONCEPT\"", "id": "\"ANTI-NUCLEAR ANTIBODIES (ANAS)\"", "label": "\"ANTI-NUCLEAR ANTIBODIES (ANAS)\"", "shape": "dot", "size": 10, "source_id": "chunk-3ae28088c4f039d981f2d5100cb16987"}, {"color": "#97c2fc", "description": "\"Anti-SSA antibodies are autoantibodies that can be present in the serum of patients with NMOSD, supporting the diagnosis.\"", "entity_type": "\"CONCEPT\"", "id": "\"ANTI-SSA ANTIBODIES\"", "label": "\"ANTI-SSA ANTIBODIES\"", "shape": "dot", "size": 10, "source_id": "chunk-3ae28088c4f039d981f2d5100cb16987"}, {"color": "#97c2fc", "description": "\"Anti-SSB antibodies are autoantibodies that can be present in the serum of patients with NMOSD, supporting the diagnosis.\"", "entity_type": "\"CONCEPT\"", "id": "\"ANTI-SSB ANTIBODIES\"", "label": "\"ANTI-SSB ANTIBODIES\"", "shape": "dot", "size": 10, "source_id": "chunk-3ae28088c4f039d981f2d5100cb16987"}, {"color": "#97c2fc", "description": "\"Anti-thyroid antibodies are autoantibodies that can be present in the serum of patients with NMOSD, supporting the diagnosis.\"", "entity_type": "\"CONCEPT\"", "id": "\"ANTI-THYROID ANTIBODIES\"", "label": "\"ANTI-THYROID ANTIBODIES\"", "shape": "dot", "size": 10, "source_id": "chunk-3ae28088c4f039d981f2d5100cb16987"}, {"color": "#97c2fc", "description": "\"MOG antibodies are found in a significant portion of AQP4\u2010IgG negative NMOSD patients, indicating a different clinical presentation and course.\"", "entity_type": "\"CONCEPT\"", "id": "\"MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG) ANTIBODIES\"", "label": "\"MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG) ANTIBODIES\"", "shape": "dot", "size": 10, "source_id": "chunk-3ae28088c4f039d981f2d5100cb16987"}, {"color": "#97c2fc", "description": "\"N-Methyl-D-Aspartate Receptor Antibodies can be present in patients with NMOSD, particularly in those with tumors, indicating a complex relationship.\"", "entity_type": "\"UNKNOWN\"", "id": "\"N-METHYL-D-ASPARTATE RECEPTOR ANTIBODIES\"", "label": "\"N-METHYL-D-ASPARTATE RECEPTOR ANTIBODIES\"", "shape": "dot", "size": 10, "source_id": "chunk-3ae28088c4f039d981f2d5100cb16987"}, {"color": "#97c2fc", "description": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\u662f\u7528\u4e8e\u8bca\u65ad\u89c6\u795e\u7ecf\u810a\u9ad3\u708e\u8c31\u7cfb\u75be\u75c5\u7684\u4e00\u79cd\u6807\u51c6\uff0c\u5f3a\u8c03\u4e86AQP4-IgG\u7684\u8bca\u65ad\u7279\u5f02\u6027\uff0c\u4f46\u4ecd\u7136\u5b58\u5728\u5047\u9633\u6027\u548c\u5047\u9634\u6027\u7684\u60c5\u51b5\u3002\"", "entity_type": "\"EVENT\"", "id": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\"", "label": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"2006\u5e74NMO\u8bca\u65ad\u6807\u51c6\u662f\u7528\u4e8e\u8bca\u65ad\u89c6\u795e\u7ecf\u810a\u9ad3\u708e\u7684\u4e00\u79cd\u6807\u51c6\uff0c\u5b58\u5728\u4e00\u5b9a\u7684\u8bca\u65ad\u7279\u5f02\u5ea6\u53ca\u654f\u611f\u5ea6\u95ee\u9898\u3002\"", "entity_type": "\"EVENT\"", "id": "\"2006\u5e74NMO\u8bca\u65ad\u6807\u51c6\"", "label": "\"2006\u5e74NMO\u8bca\u65ad\u6807\u51c6\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u591a\u53d1\u6027\u786c\u5316\u75c7\u662f\u4e00\u79cd\u708e\u6027\u8131\u9ad3\u9798\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"MS(\u591a\u53d1\u6027\u786c\u5316\u75c7)\"", "label": "\"MS(\u591a\u53d1\u6027\u786c\u5316\u75c7)\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u6025\u6027\u64ad\u6563\u6027\u8111\u810a\u9ad3\u708e\u662f\u4e00\u79cd\u708e\u6027\u8131\u9ad3\u9798\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u6025\u6027\u64ad\u6563\u6027\u8111\u810a\u9ad3\u708e\"", "label": "\"\u6025\u6027\u64ad\u6563\u6027\u8111\u810a\u9ad3\u708e\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u5047\u7624\u578b\u8131\u9ad3\u9798\u662f\u4e00\u79cd\u708e\u6027\u8131\u9ad3\u9798\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u5047\u7624\u578b\u8131\u9ad3\u9798\"", "label": "\"\u5047\u7624\u578b\u8131\u9ad3\u9798\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u7cfb\u7edf\u6027\u7ea2\u6591\u72fc\u75ae\u662f\u4e00\u79cd\u7cfb\u7edf\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u7cfb\u7edf\u6027\u7ea2\u6591\u72fc\u75ae\"", "label": "\"\u7cfb\u7edf\u6027\u7ea2\u6591\u72fc\u75ae\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u767d\u585e\u75c5\u662f\u4e00\u79cd\u7cfb\u7edf\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u767d\u585e\u75c5\"", "label": "\"\u767d\u585e\u75c5\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u5e72\u71e5\u7efc\u5408\u5f81\u662f\u4e00\u79cd\u7cfb\u7edf\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u5e72\u71e5\u7efc\u5408\u5f81\"", "label": "\"\u5e72\u71e5\u7efc\u5408\u5f81\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u7ed3\u8282\u75c5\u662f\u4e00\u79cd\u7cfb\u7edf\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u7ed3\u8282\u75c5\"", "label": "\"\u7ed3\u8282\u75c5\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u7cfb\u7edf\u6027\u8840\u7ba1\u708e\u662f\u4e00\u79cd\u7cfb\u7edf\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u7cfb\u7edf\u6027\u8840\u7ba1\u708e\"", "label": "\"\u7cfb\u7edf\u6027\u8840\u7ba1\u708e\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"Immunosuppressants are used in the sequential treatment of NMOSD to prevent relapse and manage long-term symptoms. They are often used in conjunction with corticosteroids.\"\u003cSEP\u003e\"\u514d\u75ab\u6291\u5236\u5242 are medications used to suppress the immune system, which can help reduce NMOSD recurrence but may have long-term risks such as increased susceptibility to infections and cancer.\"", "entity_type": "\"DRUG\"", "id": "\"\u514d\u75ab\u6291\u5236\u5242 (IMMUNOSUPPRESSANTS)\"", "label": "\"\u514d\u75ab\u6291\u5236\u5242 (IMMUNOSUPPRESSANTS)\"", "shape": "dot", "size": 10, "source_id": "chunk-d760189ca87cf4816e2d4c9aaa4ad24c\u003cSEP\u003echunk-4729f02f7104a27cc56e83a3aba8a1a4"}, {"color": "#97c2fc", "description": "\"High-dose hormone therapy is a treatment method used for NMOSD and NMO, which can cause side effects such as arrhythmia.\"", "entity_type": "\"EVENT\"", "id": "\"\u5927\u5242\u91cf\u6fc0\u7d20\u6cbb\u7597\"", "label": "\"\u5927\u5242\u91cf\u6fc0\u7d20\u6cbb\u7597\"", "shape": "dot", "size": 10, "source_id": "chunk-c7e6004f5252810899e285bab15d921b"}, {"color": "#97c2fc", "description": "\"Arrhythmia is a potential side effect of high-dose hormone therapy, requiring careful monitoring and management.\"", "entity_type": "\"EVENT\"", "id": "\"\u5fc3\u5f8b\u5931\u5e38\"", "label": "\"\u5fc3\u5f8b\u5931\u5e38\"", "shape": "dot", "size": 10, "source_id": "chunk-c7e6004f5252810899e285bab15d921b"}, {"color": "#97c2fc", "description": "\"Proton pump inhibitors are used to prevent upper gastrointestinal bleeding, a common side effect of high-dose hormone therapy.\"", "entity_type": "\"EVENT\"", "id": "\"\u8d28\u5b50\u6cf5\u6291\u5236\u5242\"", "label": "\"\u8d28\u5b50\u6cf5\u6291\u5236\u5242\"", "shape": "dot", "size": 10, "source_id": "chunk-c7e6004f5252810899e285bab15d921b"}, {"color": "#97c2fc", "description": "\"Stroke prevention is recommended for older patients or those with stroke risk factors during high-dose hormone therapy.\"", "entity_type": "\"EVENT\"", "id": "\"\u5352\u4e2d\u9884\u9632\"", "label": "\"\u5352\u4e2d\u9884\u9632\"", "shape": "dot", "size": 10, "source_id": "chunk-c7e6004f5252810899e285bab15d921b"}, {"color": "#97c2fc", "description": "\"Electrolyte imbalance is a common side effect of high-dose hormone therapy.\"", "entity_type": "\"EVENT\"", "id": "\"\u7535\u89e3\u8d28\u7d0a\u4e71\"", "label": "\"\u7535\u89e3\u8d28\u7d0a\u4e71\"", "shape": "dot", "size": 10, "source_id": "chunk-c7e6004f5252810899e285bab15d921b"}, {"color": "#97c2fc", "description": "\"Abnormal blood sugar, blood pressure, and lipid levels are common side effects of high-dose hormone therapy.\"", "entity_type": "\"EVENT\"", "id": "\"\u8840\u7cd6\u3001\u8840\u538b\u3001\u8840\u8102\u5f02\u5e38\"", "label": "\"\u8840\u7cd6\u3001\u8840\u538b\u3001\u8840\u8102\u5f02\u5e38\"", "shape": "dot", "size": 10, "source_id": "chunk-c7e6004f5252810899e285bab15d921b"}, {"color": "#97c2fc", "description": "\"Upper gastrointestinal bleeding is a common side effect of high-dose hormone therapy.\"", "entity_type": "\"EVENT\"", "id": "\"\u4e0a\u6d88\u5316\u9053\u51fa\u8840\"", "label": "\"\u4e0a\u6d88\u5316\u9053\u51fa\u8840\"", "shape": "dot", "size": 10, "source_id": "chunk-c7e6004f5252810899e285bab15d921b"}, {"color": "#97c2fc", "description": "\"Osteoporosis and avascular necrosis of the femoral head are potential complications of long-term high-dose hormone therapy.\"", "entity_type": "\"EVENT\"", "id": "\"\u9aa8\u8d28\u758f\u677e\u3001\u80a1\u9aa8\u5934\u574f\u6b7b\"", "label": "\"\u9aa8\u8d28\u758f\u677e\u3001\u80a1\u9aa8\u5934\u574f\u6b7b\"", "shape": "dot", "size": 10, "source_id": "chunk-c7e6004f5252810899e285bab15d921b"}, {"color": "#97c2fc", "description": "\"\u7f8e\u53f8\u94a0 (Uromitexan) \u662f\u4e00\u79cd\u836f\u7269\uff0c\u7528\u4e8e\u9884\u9632\u73af\u78f7\u9170\u80fa\u5f15\u8d77\u7684\u51fa\u8840\u6027\u8180\u80f1\u708e\u3002\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u7f8e\u53f8\u94a0 (UROMITEXAN)\"", "label": "\"\u7f8e\u53f8\u94a0 (UROMITEXAN)\"", "shape": "dot", "size": 10, "source_id": "chunk-61b576d65721d15b39a0c520f28e6ee6"}, {"color": "#97c2fc", "description": "\"\u786b\u4ee3\u560c\u5464\u7532\u57fa\u8f6c\u79fb\u9176 (TMTP) is an enzyme that can be tested to avoid severe adverse reactions to\u786b\u5511\u560c\u5464.\"", "entity_type": "\"ENZYME\"", "id": "\"\u786b\u4ee3\u560c\u5464\u7532\u57fa\u8f6c\u79fb\u9176 (TMTP)\"", "label": "\"\u786b\u4ee3\u560c\u5464\u7532\u57fa\u8f6c\u79fb\u9176 (TMTP)\"", "shape": "dot", "size": 10, "source_id": "chunk-b9071098864a619d35d144407f2b30d2"}, {"color": "#97c2fc", "description": "\"B\u7ec6\u80de\u662f\u4e00\u79cd\u514d\u75ab\u7ec6\u80de\uff0c\u5229\u59a5\u6614\u5355\u6297\u901a\u8fc7\u6d88\u51cfB\u7ec6\u80de\u6765\u51cf\u5c11NMOSD\u7684\u590d\u53d1\u548c\u51cf\u7f13\u795e\u7ecf\u529f\u80fd\u969c\u788d\u8fdb\u5c55\u3002\"", "entity_type": "\"ORGANIZATION\"", "id": "\"B\u7ec6\u80de\"", "label": "\"B\u7ec6\u80de\"", "shape": "dot", "size": 10, "source_id": "chunk-64c89732b9f2941c9331e3813eeb9803"}, {"color": "#97c2fc", "description": "\"\u8fdb\u884c\u6027\u591a\u7076\u6027\u767d\u8d28\u8111\u75c5\u662f\u4e00\u79cd\u4e25\u91cd\u7684\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\uff0c\u6709\u6587\u732e\u62a5\u9053\u5728\u4f7f\u7528\u5229\u59a5\u6614\u5355\u6297\u6cbb\u7597\u80bf\u7624\u6216\u7c7b\u98ce\u6e7f\u5173\u8282\u708e\u65f6\u53d1\u751f\uff0c\u4f46\u5927\u591a\u6570\u75c5\u4f8b\u5408\u7528\u4e86\u5176\u4ed6\u514d\u75ab\u6291\u5236\u5242\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u8fdb\u884c\u6027\u591a\u7076\u6027\u767d\u8d28\u8111\u75c5\"", "label": "\"\u8fdb\u884c\u6027\u591a\u7076\u6027\u767d\u8d28\u8111\u75c5\"", "shape": "dot", "size": 10, "source_id": "chunk-64c89732b9f2941c9331e3813eeb9803"}, {"color": "#97c2fc", "description": "\"The use of immunosuppressants in reproductive age patients, both male and female, can have significant risks for the fetus or newborn, requiring careful management.\"", "entity_type": "\"UNKNOWN\"", "id": "\"\u751f\u80b2\u671f\"", "label": "\"\u751f\u80b2\u671f\"", "shape": "dot", "size": 10, "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4"}, {"color": "#97c2fc", "description": "\"IVIg (\u4e19\u79cd\u7403\u86cb\u767d)\u63a8\u8350\u5728\u598a\u5a20\u671f\u4f7f\u7528\uff0c\u5177\u6709A\u7ea7\u63a8\u8350\uff0c\u54fa\u4e73\u671f\u4f7f\u7528\u5177\u6709D\u7ea7\u63a8\u8350\u3002\"", "entity_type": "\"DRUG\"", "id": "\"IVIG (\u4e19\u79cd\u7403\u86cb\u767d)\"", "label": "\"IVIG (\u4e19\u79cd\u7403\u86cb\u767d)\"", "shape": "dot", "size": 10, "source_id": "chunk-08e2af106947799f5d0790038b946347"}, {"color": "#97c2fc", "description": "\"\u9ea6\u8003\u915a\u9178\u916f\u7981\u5fcc\u5728\u598a\u5a20\u671f\u95f4\u4f7f\u7528\uff0c\u8ba1\u5212\u6000\u5b55\u524d\u81f3\u5c116\u5468\u5e94\u505c\u7528\uff0c\u54fa\u4e73\u671f\u4e0d\u5efa\u8bae\u4f7f\u7528\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u9ea6\u8003\u915a\u9178\u916f\"", "label": "\"\u9ea6\u8003\u915a\u9178\u916f\"", "shape": "dot", "size": 10, "source_id": "chunk-08e2af106947799f5d0790038b946347"}, {"color": "#97c2fc", "description": "\"\u6cfc\u5c3c\u677e\u9f99\u662f\u4e00\u79cd\u6fc0\u7d20\uff0c\u63a8\u8350\u5728\u598a\u5a20\u548c\u54fa\u4e73\u671f\u4f7f\u7528\uff0c\u5177\u6709A\u7ea7\u63a8\u8350\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u6cfc\u5c3c\u677e\u9f99\"", "label": "\"\u6cfc\u5c3c\u677e\u9f99\"", "shape": "dot", "size": 10, "source_id": "chunk-08e2af106947799f5d0790038b946347"}, {"color": "#97c2fc", "description": "\"\u7532\u6cfc\u5c3c\u677e\u9f99\u662f\u4e00\u79cd\u6fc0\u7d20\uff0c\u80ce\u76d8\u8f6c\u8fd0\u7387\u4e0e\u6cfc\u5c3c\u677e\u9f99\u76f8\u4f3c\uff0c\u4ea7\u751f\u7b49\u6548\u6297\u708e\u4f5c\u7528\u6240\u9700\u5242\u91cf\u4e3a\u6cfc\u5c3c\u677e\u9f99\u768480%\uff0c\u63a8\u8350\u5728\u598a\u5a20\u548c\u54fa\u4e73\u671f\u4f7f\u7528\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u7532\u6cfc\u5c3c\u677e\u9f99\"", "label": "\"\u7532\u6cfc\u5c3c\u677e\u9f99\"", "shape": "dot", "size": 10, "source_id": "chunk-08e2af106947799f5d0790038b946347"}, {"color": "#97c2fc", "description": "\"\u5df4\u6c2f\u82ac\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u75db\u6027\u75c9\u631b\u548c\u987d\u56fa\u6027\u5443\u9006\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u5df4\u6c2f\u82ac\"", "label": "\"\u5df4\u6c2f\u82ac\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u5df4\u6c2f\u82ac\u7528\u4e8e\u6cbb\u7597\u75db\u6027\u75c9\u631b\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "entity_type": "\"UNKNOWN\"", "id": "\"\u75db\u6027\u75c9\u631b\"", "label": "\"\u75db\u6027\u75c9\u631b\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u5df4\u6c2f\u82ac\u7528\u4e8e\u6cbb\u7597\u987d\u56fa\u6027\u5443\u9006\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "entity_type": "\"UNKNOWN\"", "id": "\"\u987d\u56fa\u6027\u5443\u9006\"", "label": "\"\u987d\u56fa\u6027\u5443\u9006\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u963f\u7c73\u66ff\u6797\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u6162\u6027\u75bc\u75db\u548c\u611f\u89c9\u5f02\u5e38\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u963f\u7c73\u66ff\u6797\"", "label": "\"\u963f\u7c73\u66ff\u6797\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u963f\u7c73\u66ff\u6797\u7528\u4e8e\u6cbb\u7597\u6162\u6027\u75bc\u75db\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "entity_type": "\"UNKNOWN\"", "id": "\"\u6162\u6027\u75bc\u75db\"", "label": "\"\u6162\u6027\u75bc\u75db\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u963f\u7c73\u66ff\u6797\u7528\u4e8e\u6cbb\u7597\u611f\u89c9\u5f02\u5e38\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "entity_type": "\"UNKNOWN\"", "id": "\"\u611f\u89c9\u5f02\u5e38\"", "label": "\"\u611f\u89c9\u5f02\u5e38\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u83ab\u8fbe\u975e\u5c3c\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u4e4f\u529b\u548c\u75b2\u52b3\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u83ab\u8fbe\u975e\u5c3c (MODAFINIL)\"", "label": "\"\u83ab\u8fbe\u975e\u5c3c (MODAFINIL)\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u83ab\u8fbe\u975e\u5c3c\u7528\u4e8e\u6cbb\u7597\u4e4f\u529b\u548c\u75b2\u52b3\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "entity_type": "\"UNKNOWN\"", "id": "\"\u4e4f\u529b\u3001\u75b2\u52b3\"", "label": "\"\u4e4f\u529b\u3001\u75b2\u52b3\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u91d1\u521a\u70f7\u80fa\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u4e4f\u529b\u548c\u75b2\u52b3\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u91d1\u521a\u70f7\u80fa\"", "label": "\"\u91d1\u521a\u70f7\u80fa\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u76d0\u9178\u82ef\u6d77\u7d22\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u9707\u98a4\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u76d0\u9178\u82ef\u6d77\u7d22\"", "label": "\"\u76d0\u9178\u82ef\u6d77\u7d22\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u76d0\u9178\u82ef\u6d77\u7d22\u7528\u4e8e\u6cbb\u7597\u9707\u98a4\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "entity_type": "\"UNKNOWN\"", "id": "\"\u9707\u98a4\"", "label": "\"\u9707\u98a4\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u76d0\u9178\u963f\u7f57\u6d1b\u5c14\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u9707\u98a4\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u76d0\u9178\u963f\u7f57\u6d1b\u5c14\"", "label": "\"\u76d0\u9178\u963f\u7f57\u6d1b\u5c14\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u4e19\u54aa\u55ea\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u5c3f\u5931\u7981\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u4e19\u54aa\u55ea\"", "label": "\"\u4e19\u54aa\u55ea\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u4e19\u54aa\u55ea\u7528\u4e8e\u6cbb\u7597\u5c3f\u5931\u7981\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "entity_type": "\"UNKNOWN\"", "id": "\"\u5c3f\u5931\u7981\"", "label": "\"\u5c3f\u5931\u7981\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u5965\u6614\u5e03\u5b81\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u5c3f\u5931\u7981\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u5965\u6614\u5e03\u5b81\"", "label": "\"\u5965\u6614\u5e03\u5b81\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u54cc\u5511\u55ea\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u5c3f\u5931\u7981\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u54cc\u5511\u55ea\"", "label": "\"\u54cc\u5511\u55ea\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u76d0\u9178\u5766\u7d22\u7f57\u8f9b\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u5c3f\u5931\u7981\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u76d0\u9178\u5766\u7d22\u7f57\u8f9b\"", "label": "\"\u76d0\u9178\u5766\u7d22\u7f57\u8f9b\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u7f13\u6cfb\u836f\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u4fbf\u79d8\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u7f13\u6cfb\u836f\"", "label": "\"\u7f13\u6cfb\u836f\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u7f13\u6cfb\u836f\u7528\u4e8e\u6cbb\u7597\u4fbf\u79d8\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "entity_type": "\"UNKNOWN\"", "id": "\"\u4fbf\u79d8\"", "label": "\"\u4fbf\u79d8\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u8089\u6bd2\u6bd2\u7d20A\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u4e0b\u80a2\u75c9\u631b\u6027\u808c\u5f20\u529b\u589e\u9ad8\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u8089\u6bd2\u6bd2\u7d20A\"", "label": "\"\u8089\u6bd2\u6bd2\u7d20A\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u8089\u6bd2\u6bd2\u7d20A\u7528\u4e8e\u6cbb\u7597\u4e0b\u80a2\u75c9\u631b\u6027\u808c\u5f20\u529b\u589e\u9ad8\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "entity_type": "\"UNKNOWN\"", "id": "\"\u4e0b\u80a2\u75c9\u631b\u6027\u808c\u5f20\u529b\u589e\u9ad8\"", "label": "\"\u4e0b\u80a2\u75c9\u631b\u6027\u808c\u5f20\u529b\u589e\u9ad8\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u80c6\u78b1\u916f\u9176\u6291\u5236\u5242\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u8ba4\u77e5\u969c\u788d\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u80c6\u78b1\u916f\u9176\u6291\u5236\u5242\"", "label": "\"\u80c6\u78b1\u916f\u9176\u6291\u5236\u5242\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u80c6\u78b1\u916f\u9176\u6291\u5236\u5242\u7528\u4e8e\u6cbb\u7597\u8ba4\u77e5\u969c\u788d\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "entity_type": "\"UNKNOWN\"", "id": "\"\u8ba4\u77e5\u969c\u788d\"", "label": "\"\u8ba4\u77e5\u969c\u788d\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"NMOSD\u7684\u5eb7\u590d\u6cbb\u7597\u662f\u6307\u5bf9\u4f34\u6709\u80a2\u4f53\u3001\u541e\u54bd\u7b49\u529f\u80fd\u969c\u788d\u7684\u60a3\u8005\u8fdb\u884c\u7684\u5eb7\u590d\u8bad\u7ec3\u3002\"", "entity_type": "\"EVENT\"", "id": "\"NMOSD\u7684\u5eb7\u590d\u6cbb\u7597\"", "label": "\"NMOSD\u7684\u5eb7\u590d\u6cbb\u7597\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u4e13\u4e1a\u533b\u751f\u662f\u6307\u8d1f\u8d23\u6307\u5bfc\u60a3\u8005\u8fdb\u884c\u529f\u80fd\u5eb7\u590d\u8bad\u7ec3\u7684\u533b\u7597\u4eba\u5458\u3002\"", "entity_type": "\"PERSON\"", "id": "\"\u4e13\u4e1a\u533b\u751f\"", "label": "\"\u4e13\u4e1a\u533b\u751f\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"SSRI\u7528\u4e8e\u6cbb\u7597\u6162\u6027\u75bc\u75db\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "entity_type": "\"UNKNOWN\"", "id": "\"SSRI\"", "label": "\"SSRI\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"SNRI\u7528\u4e8e\u6cbb\u7597\u6162\u6027\u75bc\u75db\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "entity_type": "\"UNKNOWN\"", "id": "\"SNRI\"", "label": "\"SNRI\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"NaSSA\u7528\u4e8e\u6cbb\u7597\u6162\u6027\u75bc\u75db\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "entity_type": "\"UNKNOWN\"", "id": "\"NASSA\"", "label": "\"NASSA\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"SSRI\u7528\u4e8e\u6cbb\u7597\u6291\u90c1\u7126\u8651\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "entity_type": "\"UNKNOWN\"", "id": "\"\u6291\u90c1\u7126\u8651\"", "label": "\"\u6291\u90c1\u7126\u8651\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"MS is a distinct disease from NMO, characterized by immune-mediated demyelination in the central nervous system (CNS).\"", "entity_type": "\"EVENT\"", "id": "\"\u591a\u53d1\u6027\u786c\u5316(MULTIPLE SCLEROSIS, MS)\"", "label": "\"\u591a\u53d1\u6027\u786c\u5316(MULTIPLE SCLEROSIS, MS)\"", "shape": "dot", "size": 10, "source_id": "chunk-d3c46123897bf67b8ac7a319f7459d5e"}, {"color": "#97c2fc", "description": "\"NMO (Neuromyelitis Optica) is a specific form of NMOSD, characterized by severe inflammation of the optic nerves and spinal cord.\"", "entity_type": "\"EVENT\"", "id": "\"NMO (NEUROMYELITIS OPTICA)\"", "label": "\"NMO (NEUROMYELITIS OPTICA)\"", "shape": "dot", "size": 10, "source_id": "chunk-1508a751986aeefee59f14762ad947b8"}, {"color": "#97c2fc", "description": "\"\u7f3a\u8840\u6027\u89c6\u795e\u7ecf\u75c5\u662f\u4e00\u79cd\u8840\u7ba1\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u7f3a\u8840\u6027\u89c6\u795e\u7ecf\u75c5\"", "label": "\"\u7f3a\u8840\u6027\u89c6\u795e\u7ecf\u75c5\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u810a\u9ad3\u786c\u810a\u819c\u52a8\u9759\u8109\u7618\u662f\u4e00\u79cd\u8840\u7ba1\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u810a\u9ad3\u786c\u810a\u819c\u52a8\u9759\u8109\u7618\"", "label": "\"\u810a\u9ad3\u786c\u810a\u819c\u52a8\u9759\u8109\u7618\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u810a\u9ad3\u8840\u7ba1\u7578\u5f62\u662f\u4e00\u79cd\u8840\u7ba1\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u810a\u9ad3\u8840\u7ba1\u7578\u5f62\"", "label": "\"\u810a\u9ad3\u8840\u7ba1\u7578\u5f62\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u4e9a\u6025\u6027\u574f\u6b7b\u6027\u810a\u9ad3\u75c5\u662f\u4e00\u79cd\u8840\u7ba1\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u4e9a\u6025\u6027\u574f\u6b7b\u6027\u810a\u9ad3\u75c5\"", "label": "\"\u4e9a\u6025\u6027\u574f\u6b7b\u6027\u810a\u9ad3\u75c5\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u7ed3\u6838\u662f\u4e00\u79cd\u611f\u67d3\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u7ed3\u6838\"", "label": "\"\u7ed3\u6838\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u827e\u6ecb\u75c5\u662f\u4e00\u79cd\u611f\u67d3\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u827e\u6ecb\u75c5\"", "label": "\"\u827e\u6ecb\u75c5\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u6885\u6bd2\u662f\u4e00\u79cd\u611f\u67d3\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u6885\u6bd2\"", "label": "\"\u6885\u6bd2\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u5e03\u6c0f\u6746\u83cc\u611f\u67d3\u662f\u4e00\u79cd\u611f\u67d3\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u5e03\u6c0f\u6746\u83cc\u611f\u67d3\"", "label": "\"\u5e03\u6c0f\u6746\u83cc\u611f\u67d3\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u70ed\u5e26\u75c9\u631b\u6027\u622a\u762b\u662f\u4e00\u79cd\u611f\u67d3\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u70ed\u5e26\u75c9\u631b\u6027\u622a\u762b\"", "label": "\"\u70ed\u5e26\u75c9\u631b\u6027\u622a\u762b\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u4e2d\u6bd2\u6027\u89c6\u795e\u7ecf\u75c5\u662f\u4e00\u79cd\u4ee3\u8c22\u4e2d\u6bd2\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u4e2d\u6bd2\u6027\u89c6\u795e\u7ecf\u75c5\"", "label": "\"\u4e2d\u6bd2\u6027\u89c6\u795e\u7ecf\u75c5\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u4e9a\u6025\u6027\u8054\u5408\u53d8\u6027\u662f\u4e00\u79cd\u4ee3\u8c22\u4e2d\u6bd2\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u4e9a\u6025\u6027\u8054\u5408\u53d8\u6027\"", "label": "\"\u4e9a\u6025\u6027\u8054\u5408\u53d8\u6027\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u809d\u6027\u810a\u9ad3\u75c5\u662f\u4e00\u79cd\u4ee3\u8c22\u4e2d\u6bd2\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u809d\u6027\u810a\u9ad3\u75c5\"", "label": "\"\u809d\u6027\u810a\u9ad3\u75c5\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"Wernick\u8111\u75c5\u662f\u4e00\u79cd\u4ee3\u8c22\u4e2d\u6bd2\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"WERNICK\u8111\u75c5\"", "label": "\"WERNICK\u8111\u75c5\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u7f3a\u8840\u7f3a\u6c27\u6027\u8111\u75c5\u662f\u4e00\u79cd\u4ee3\u8c22\u4e2d\u6bd2\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u7f3a\u8840\u7f3a\u6c27\u6027\u8111\u75c5\"", "label": "\"\u7f3a\u8840\u7f3a\u6c27\u6027\u8111\u75c5\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"Leber\u89c6\u795e\u7ecf\u75c5\u662f\u4e00\u79cd\u9057\u4f20\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"LEBER\u89c6\u795e\u7ecf\u75c5\"", "label": "\"LEBER\u89c6\u795e\u7ecf\u75c5\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u9057\u4f20\u6027\u75c9\u631b\u6027\u622a\u762b\u662f\u4e00\u79cd\u9057\u4f20\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u9057\u4f20\u6027\u75c9\u631b\u6027\u622a\u762b\"", "label": "\"\u9057\u4f20\u6027\u75c9\u631b\u6027\u622a\u762b\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u80be\u4e0a\u817a\u8111\u767d\u8d28\u8425\u517b\u4e0d\u826f\u662f\u4e00\u79cd\u9057\u4f20\u6027\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u80be\u4e0a\u817a\u8111\u767d\u8d28\u8425\u517b\u4e0d\u826f\"", "label": "\"\u80be\u4e0a\u817a\u8111\u767d\u8d28\u8425\u517b\u4e0d\u826f\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u810a\u9ad3\u80f6\u8d28\u7624\u662f\u4e00\u79cd\u80bf\u7624\u53ca\u526f\u80bf\u7624\u76f8\u5173\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u810a\u9ad3\u80f6\u8d28\u7624\"", "label": "\"\u810a\u9ad3\u80f6\u8d28\u7624\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u5ba4\u7ba1\u819c\u7624\u662f\u4e00\u79cd\u80bf\u7624\u53ca\u526f\u80bf\u7624\u76f8\u5173\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u5ba4\u7ba1\u819c\u7624\"", "label": "\"\u5ba4\u7ba1\u819c\u7624\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u810a\u9ad3\u526f\u80bf\u7624\u7efc\u5408\u5f81\u662f\u4e00\u79cd\u80bf\u7624\u53ca\u526f\u80bf\u7624\u76f8\u5173\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u810a\u9ad3\u526f\u80bf\u7624\u7efc\u5408\u5f81\"", "label": "\"\u810a\u9ad3\u526f\u80bf\u7624\u7efc\u5408\u5f81\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u9885\u5e95\u7578\u5f62\u662f\u4e00\u79cd\u5176\u4ed6\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u9885\u5e95\u7578\u5f62\"", "label": "\"\u9885\u5e95\u7578\u5f62\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"\u810a\u9ad3\u538b\u8feb\u75c7\u662f\u4e00\u79cd\u5176\u4ed6\u75be\u75c5\uff0c\u9700\u8981\u4e0eNMOSD\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "entity_type": "\"EVENT\"", "id": "\"\u810a\u9ad3\u538b\u8feb\u75c7\"", "label": "\"\u810a\u9ad3\u538b\u8feb\u75c7\"", "shape": "dot", "size": 10, "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea"}, {"color": "#97c2fc", "description": "\"MS (Multiple Sclerosis) is a chronic inflammatory disease of the central nervous system.\"", "entity_type": "\"EVENT\"", "id": "\"MS\"", "label": "\"MS\"", "shape": "dot", "size": 10, "source_id": "chunk-c7e6004f5252810899e285bab15d921b"}, {"color": "#97c2fc", "description": "\"AQP\u2010IgG (Aquaporin-4 Antibody) is an antibody associated with NMOSD and NMO, indicating the presence of these conditions.\"", "entity_type": "\"EVENT\"", "id": "\"AQP\u2010IGG\"", "label": "\"AQP\u2010IGG\"", "shape": "dot", "size": 10, "source_id": "chunk-c7e6004f5252810899e285bab15d921b"}, {"color": "#97c2fc", "description": "\"CSF (Cerebrospinal Fluid) is the fluid surrounding the brain and spinal cord, often analyzed in the diagnosis of NMOSD and NMO.\"", "entity_type": "\"EVENT\"", "id": "\"CSF\"", "label": "\"CSF\"", "shape": "dot", "size": 10, "source_id": "chunk-c7e6004f5252810899e285bab15d921b"}, {"color": "#97c2fc", "description": "\"\u7532\u6c28\u8776\u5464 is an immunosuppressant that can be used alone or in combination with \u6cfc\u5c3c\u677e to reduce NMOSD recurrence and functional impairment. It is well-tolerated, affordable, and suitable for patients who cannot tolerate other immunosuppressants.\"", "entity_type": "\"DRUG\"", "id": "\"\u7532\u6c28\u8776\u5464 (METHOTREXATE)\"", "label": "\"\u7532\u6c28\u8776\u5464 (METHOTREXATE)\"", "shape": "dot", "size": 10, "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4"}, {"color": "#97c2fc", "description": "\"IVIg is used in intermittent low doses to reduce NMOSD recurrence, but its effectiveness is based on open clinical trials, and more robust studies are needed.\"", "entity_type": "\"DRUG\"", "id": "\"IVIG (INTRAVENOUS IMMUNOGLOBULIN)\"", "label": "\"IVIG (INTRAVENOUS IMMUNOGLOBULIN)\"", "shape": "dot", "size": 10, "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4"}, {"color": "#97c2fc", "description": "\"\u73af\u5b62\u7d20A is an immunosuppressant recommended at a dose of 2-3 mg/kg/day, administered twice daily, with dose adjustments based on blood levels. It requires monitoring for renal toxicity.\"", "entity_type": "\"DRUG\"", "id": "\"\u73af\u5b62\u7d20A (CYCLOSPORINE A)\"", "label": "\"\u73af\u5b62\u7d20A (CYCLOSPORINE A)\"", "shape": "dot", "size": 10, "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4"}, {"color": "#97c2fc", "description": "\"\u03b2 \u5e72\u6270\u7d20 is a treatment for multiple sclerosis (MS) but can worsen NMOSD symptoms.\"", "entity_type": "\"DRUG\"", "id": "\"\u0392 \u5e72\u6270\u7d20 (INTERFERON BETA)\"", "label": "\"\u0392 \u5e72\u6270\u7d20 (INTERFERON BETA)\"", "shape": "dot", "size": 10, "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4"}, {"color": "#97c2fc", "description": "\"\u82ac\u6208\u83ab\u5fb7 is a treatment for MS but can exacerbate NMOSD symptoms.\"", "entity_type": "\"DRUG\"", "id": "\"\u82ac\u6208\u83ab\u5fb7 (FINGOLIMOD)\"", "label": "\"\u82ac\u6208\u83ab\u5fb7 (FINGOLIMOD)\"", "shape": "dot", "size": 10, "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4"}, {"color": "#97c2fc", "description": "\"\u90a3\u4ed6\u73e0\u5355\u6297 is a treatment for MS but can worsen NMOSD symptoms.\"", "entity_type": "\"DRUG\"", "id": "\"\u90a3\u4ed6\u73e0\u5355\u6297 (NATALIZUMAB)\"", "label": "\"\u90a3\u4ed6\u73e0\u5355\u6297 (NATALIZUMAB)\"", "shape": "dot", "size": 10, "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4"}, {"color": "#97c2fc", "description": "\"\u598a\u5a20\u671f refers to the period of pregnancy, during which NMOSD patients have a similar risk of recurrence as non-pregnant periods but a higher risk postpartum. Immunosuppressants can have adverse effects on the fetus or newborn.\"", "entity_type": "\"EVENT\"", "id": "\"\u598a\u5a20\u671f (PREGNANCY)\"", "label": "\"\u598a\u5a20\u671f (PREGNANCY)\"", "shape": "dot", "size": 10, "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4"}, {"color": "#97c2fc", "description": "\"\u751f\u80b2\u671f refers to the reproductive age period, during which the use of immunosuppressants in both male and female patients can have significant risks for the fetus or newborn.\"", "entity_type": "\"EVENT\"", "id": "\"\u751f\u80b2\u671f (REPRODUCTIVE AGE)\"", "label": "\"\u751f\u80b2\u671f (REPRODUCTIVE AGE)\"", "shape": "dot", "size": 10, "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4"}, {"color": "#97c2fc", "description": "\"\u5361\u9a6c\u897f\u5e73\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u75db\u6027\u75c9\u631b\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u5361\u9a6c\u897f\u5e73\"", "label": "\"\u5361\u9a6c\u897f\u5e73\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u52a0\u5df4\u55b7\u6c40\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u75db\u6027\u75c9\u631b\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u52a0\u5df4\u55b7\u6c40\"", "label": "\"\u52a0\u5df4\u55b7\u6c40\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u666e\u745e\u5df4\u6797\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u75db\u6027\u75c9\u631b\u548c\u6162\u6027\u75bc\u75db\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u666e\u745e\u5df4\u6797\"", "label": "\"\u666e\u745e\u5df4\u6797\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"SSRI\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u6162\u6027\u75bc\u75db\u3001\u611f\u89c9\u5f02\u5e38\u3001\u6291\u90c1\u7126\u8651\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u9009\u62e9\u60275\u2010\u7f9f\u8272\u80fa\u518d\u6444\u53d6\u6291\u5236\u5242 (SSRI)\"", "label": "\"\u9009\u62e9\u60275\u2010\u7f9f\u8272\u80fa\u518d\u6444\u53d6\u6291\u5236\u5242 (SSRI)\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"SNRI\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u6162\u6027\u75bc\u75db\u3001\u611f\u89c9\u5f02\u5e38\u3001\u6291\u90c1\u7126\u8651\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u53bb\u7532\u80be\u4e0a\u817a\u7d20\u518d\u6444\u53d6\u6291\u5236\u5242 (SNRI)\"", "label": "\"\u53bb\u7532\u80be\u4e0a\u817a\u7d20\u518d\u6444\u53d6\u6291\u5236\u5242 (SNRI)\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"NaSSA\u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u6162\u6027\u75bc\u75db\u3001\u611f\u89c9\u5f02\u5e38\u3001\u6291\u90c1\u7126\u8651\u7684\u836f\u7269\u3002\"", "entity_type": "\"DRUG\"", "id": "\"\u53bb\u7532\u80be\u4e0a\u817a\u7d20\u80fd\u4e0e\u7279\u5f02\u60275\u2010\u7f9f\u8272\u80fa\u80fd\u6297\u6291\u90c1\u836f\u7269 (NASSA)\"", "label": "\"\u53bb\u7532\u80be\u4e0a\u817a\u7d20\u80fd\u4e0e\u7279\u5f02\u60275\u2010\u7f9f\u8272\u80fa\u80fd\u6297\u6291\u90c1\u836f\u7269 (NASSA)\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u60a3\u8005\u53ca\u4eb2\u5c5e\u662f\u6307\u63a5\u53d7\u6cbb\u7597\u548c\u5ba3\u6559\u6307\u5bfc\u7684\u4e2a\u4f53\u3002\"", "entity_type": "\"PERSON\"", "id": "\"\u60a3\u8005\u53ca\u4eb2\u5c5e\"", "label": "\"\u60a3\u8005\u53ca\u4eb2\u5c5e\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u533b\u52a1\u4eba\u5458\u662f\u6307\u63d0\u4f9b\u533b\u7597\u548c\u5ba3\u6559\u6307\u5bfc\u7684\u533b\u7597\u5de5\u4f5c\u8005\u3002\"", "entity_type": "\"PERSON\"", "id": "\"\u533b\u52a1\u4eba\u5458\"", "label": "\"\u533b\u52a1\u4eba\u5458\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"\u8fd9\u4e9b\u65b9\u9762\u662f\u6307\u533b\u52a1\u4eba\u5458\u5728\u60a3\u8005\u751f\u6d3b\u4e2d\u63d0\u4f9b\u7684\u5408\u7406\u5efa\u8bae\u3002\"", "entity_type": "\"CONCEPT\"", "id": "\"\u9057\u4f20\u3001\u5a5a\u59fb\u3001\u598a\u5a20\u3001\u996e\u98df\u3001\u5fc3\u7406\u53ca\u7528\u836f\u7b49\u751f\u6d3b\u7684\u5404\u4e2a\u65b9\u9762\"", "label": "\"\u9057\u4f20\u3001\u5a5a\u59fb\u3001\u598a\u5a20\u3001\u996e\u98df\u3001\u5fc3\u7406\u53ca\u7528\u836f\u7b49\u751f\u6d3b\u7684\u5404\u4e2a\u65b9\u9762\"", "shape": "dot", "size": 10, "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360"}, {"color": "#97c2fc", "description": "\"Tianjin Huanhu Hospital is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u5929\u6d25\u5e02\u73af\u6e56\u533b\u9662\"", "label": "\"\u5929\u6d25\u5e02\u73af\u6e56\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u534e\u4e2d\u79d1\u6280\u5927\u5b66\u540c\u6d4e\u533b\u5b66\u9662\u9644\u5c5e\u540c\u6d4e\u533b\u9662\"", "label": "\"\u534e\u4e2d\u79d1\u6280\u5927\u5b66\u540c\u6d4e\u533b\u5b66\u9662\u9644\u5c5e\u540c\u6d4e\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Ruijin Hospital, Shanghai is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u4e0a\u6d77\u745e\u91d1\u533b\u9662\"", "label": "\"\u4e0a\u6d77\u745e\u91d1\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Huashan Hospital, Fudan University is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u590d\u65e6\u5927\u5b66\u9644\u5c5e\u534e\u5c71\u533b\u9662\"", "label": "\"\u590d\u65e6\u5927\u5b66\u9644\u5c5e\u534e\u5c71\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Ningxia Medical University General Hospital is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u5b81\u590f\u533b\u79d1\u5927\u5b66\u603b\u533b\u9662\"", "label": "\"\u5b81\u590f\u533b\u79d1\u5927\u5b66\u603b\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Qianfoshan Hospital, Shandong University (Shandong Qianfoshan Hospital) is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u5c71\u4e1c\u5927\u5b66\u9644\u5c5e\u5343\u4f5b\u5c71\u533b\u9662(\u5c71\u4e1c\u7701\u5343\u4f5b\u5c71\u533b\u9662)\"", "label": "\"\u5c71\u4e1c\u5927\u5b66\u9644\u5c5e\u5343\u4f5b\u5c71\u533b\u9662(\u5c71\u4e1c\u7701\u5343\u4f5b\u5c71\u533b\u9662)\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Guangzhou Medical University Second Hospital is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u5e7f\u5dde\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u7b2c\u4e8c\u533b\u9662\"", "label": "\"\u5e7f\u5dde\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u7b2c\u4e8c\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Peking University First Hospital is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u5317\u4eac\u5927\u5b66\u7b2c\u4e00\u533b\u9662\"", "label": "\"\u5317\u4eac\u5927\u5b66\u7b2c\u4e00\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Hebei Medical University Second Hospital is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u6cb3\u5317\u533b\u79d1\u5927\u5b66\u7b2c\u4e8c\u533b\u9662\"", "label": "\"\u6cb3\u5317\u533b\u79d1\u5927\u5b66\u7b2c\u4e8c\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"The Third Affiliated Hospital of Sun Yat-sen University is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u4e2d\u5c71\u5927\u5b66\u9644\u5c5e\u7b2c\u4e09\u533b\u9662\"", "label": "\"\u4e2d\u5c71\u5927\u5b66\u9644\u5c5e\u7b2c\u4e09\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"PLA General Hospital, Beijing is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u5317\u4eac\u89e3\u653e\u519b\u603b\u533b\u9662\"", "label": "\"\u5317\u4eac\u89e3\u653e\u519b\u603b\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Qinghai Provincial People\u0027s Hospital is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u9752\u6d77\u7701\u4eba\u6c11\u533b\u9662\"", "label": "\"\u9752\u6d77\u7701\u4eba\u6c11\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"The First Affiliated Hospital of Jilin University is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u5409\u6797\u5927\u5b66\u9644\u5c5e\u7b2c\u4e00\u533b\u9662\"", "label": "\"\u5409\u6797\u5927\u5b66\u9644\u5c5e\u7b2c\u4e00\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Beijing Tongren Hospital, Capital Medical University is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u9996\u90fd\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u5317\u4eac\u540c\u4ec1\u533b\u9662\"", "label": "\"\u9996\u90fd\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u5317\u4eac\u540c\u4ec1\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Qilu Hospital, Shandong University is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u5c71\u4e1c\u5927\u5b66\u9f50\u9c81\u533b\u9662\"", "label": "\"\u5c71\u4e1c\u5927\u5b66\u9f50\u9c81\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Tangdu Hospital, Fourth Military Medical University, Shaanxi is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u9655\u897f\u7701\u7b2c\u56db\u519b\u533b\u5927\u5b66\u5510\u90fd\u533b\u9662\u795e\u7ecf\u5185\u79d1\"", "label": "\"\u9655\u897f\u7701\u7b2c\u56db\u519b\u533b\u5927\u5b66\u5510\u90fd\u533b\u9662\u795e\u7ecf\u5185\u79d1\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Neurology Department, Affiliated Hospital of Inner Mongolia Medical University is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u5185\u8499\u53e4\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u533b\u9662\u795e\u7ecf\u5185\u79d1\"", "label": "\"\u5185\u8499\u53e4\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u533b\u9662\u795e\u7ecf\u5185\u79d1\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Hainan Medical University is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u6d77\u5357\u533b\u5b66\u9662\"", "label": "\"\u6d77\u5357\u533b\u5b66\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Department of Neurology, Peking University People\u0027s Hospital is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u5317\u4eac\u5927\u5b66\u4eba\u6c11\u533b\u9662\u795e\u7ecf\u5185\u79d1\"", "label": "\"\u5317\u4eac\u5927\u5b66\u4eba\u6c11\u533b\u9662\u795e\u7ecf\u5185\u79d1\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"The First Affiliated Hospital of Sun Yat-sen University is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u4e2d\u5c71\u5927\u5b66\u9644\u5c5e\u7b2c\u4e00\u533b\u9662\"", "label": "\"\u4e2d\u5c71\u5927\u5b66\u9644\u5c5e\u7b2c\u4e00\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Institute of Neurology, Guangxi Medical University is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u5e7f\u897f\u533b\u79d1\u5927\u5b66\u795e\u7ecf\u75c5\u5b66\u7814\u7a76\u6240\"", "label": "\"\u5e7f\u897f\u533b\u79d1\u5927\u5b66\u795e\u7ecf\u75c5\u5b66\u7814\u7a76\u6240\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Department of Neurology, PLA General Hospital is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u6d77\u519b\u603b\u533b\u9662\u795e\u7ecf\u5185\u79d1\"", "label": "\"\u6d77\u519b\u603b\u533b\u9662\u795e\u7ecf\u5185\u79d1\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"The First Affiliated Hospital of Chongqing Medical University is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u91cd\u5e86\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u7b2c\u4e00\u533b\u9662\"", "label": "\"\u91cd\u5e86\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u7b2c\u4e00\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Nanfang Hospital is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u5357\u65b9\u533b\u9662\"", "label": "\"\u5357\u65b9\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Beijing Tiantan Hospital, Capital Medical University is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u9996\u90fd\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u5317\u4eac\u5929\u575b\u533b\u9662\"", "label": "\"\u9996\u90fd\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u5317\u4eac\u5929\u575b\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Renji Hospital, Shanghai Jiao Tong University is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u9644\u5c5e\u4ec1\u6d4e\u533b\u9662\"", "label": "\"\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u9644\u5c5e\u4ec1\u6d4e\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Department of Neurology, South Building, PLA General Hospital is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u89e3\u653e\u519b\u603b\u533b\u9662\u5357\u697c\u795e\u7ecf\u5185\u79d1\"", "label": "\"\u89e3\u653e\u519b\u603b\u533b\u9662\u5357\u697c\u795e\u7ecf\u5185\u79d1\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Jiangxi Provincial People\u0027s Hospital is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u6c5f\u897f\u7701\u4eba\u6c11\u533b\u9662\"", "label": "\"\u6c5f\u897f\u7701\u4eba\u6c11\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Institute of Neurology, Huashan Hospital, Fudan University is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u590d\u65e6\u5927\u5b66\u9644\u5c5e\u534e\u5c71\u533b\u9662\u795e\u7ecf\u75c5\u5b66\u7814\u7a76\u6240\"", "label": "\"\u590d\u65e6\u5927\u5b66\u9644\u5c5e\u534e\u5c71\u533b\u9662\u795e\u7ecf\u75c5\u5b66\u7814\u7a76\u6240\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Department of Neurology, Peking Union Medical College Hospital is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u5317\u4eac\u534f\u548c\u533b\u9662\u795e\u7ecf\u79d1\"", "label": "\"\u5317\u4eac\u534f\u548c\u533b\u9662\u795e\u7ecf\u79d1\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Department of Neurology, Beijing Hospital is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u5317\u4eac\u533b\u9662\u795e\u7ecf\u79d1\"", "label": "\"\u5317\u4eac\u533b\u9662\u795e\u7ecf\u79d1\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Department of Neurology, Second Affiliated Hospital of Harbin Medical University is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u54c8\u5c14\u6ee8\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u4e8c\u9662\u795e\u7ecf\u5185\u79d1\"", "label": "\"\u54c8\u5c14\u6ee8\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u4e8c\u9662\u795e\u7ecf\u5185\u79d1\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Department of Neurology, Second Hospital of Lanzhou University is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u5170\u5dde\u5927\u5b66\u7b2c\u4e8c\u533b\u9662\u795e\u7ecf\u5185\u79d1\"", "label": "\"\u5170\u5dde\u5927\u5b66\u7b2c\u4e8c\u533b\u9662\u795e\u7ecf\u5185\u79d1\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Sixth People\u0027s Hospital, Shanghai Jiao Tong University is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u9644\u5c5e\u7b2c\u516d\u4eba\u6c11\u533b\u9662\"", "label": "\"\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u9644\u5c5e\u7b2c\u516d\u4eba\u6c11\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Qingdao University Affiliated Hospital is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u9752\u5c9b\u5927\u5b66\u9644\u5c5e\u533b\u9662\"", "label": "\"\u9752\u5c9b\u5927\u5b66\u9644\u5c5e\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"West China Hospital, Sichuan University is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u56db\u5ddd\u5927\u5b66\u534e\u897f\u533b\u9662\"", "label": "\"\u56db\u5ddd\u5927\u5b66\u534e\u897f\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Xiangya Hospital, Central South University is a medical institution involved in the development and research of NMOSD.\"", "entity_type": "\"ORGANIZATION\"", "id": "\"\u4e2d\u5357\u5927\u5b66\u6e58\u96c5\u533b\u9662\"", "label": "\"\u4e2d\u5357\u5927\u5b66\u6e58\u96c5\u533b\u9662\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"An Zhongping is a participant in the development and research of NMOSD, affiliated with Tianjin Huanhu Hospital.\"", "entity_type": "\"PERSON\"", "id": "\"\u5b89\u4e2d\u5e73\"", "label": "\"\u5b89\u4e2d\u5e73\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Bu Bitao is a participant in the development and research of NMOSD, affiliated with Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology.\"", "entity_type": "\"PERSON\"", "id": "\"\u535c\u78a7\u6d9b\"", "label": "\"\u535c\u78a7\u6d9b\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Zeng Lili is a participant in the development and research of NMOSD, affiliated with Ruijin Hospital, Shanghai.\"", "entity_type": "\"PERSON\"", "id": "\"\u66fe\u4e3d\u8389\"", "label": "\"\u66fe\u4e3d\u8389\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Chen Xiangjun is a participant in the development and research of NMOSD, affiliated with Huashan Hospital, Fudan University.\"", "entity_type": "\"PERSON\"", "id": "\"\u9648\u5411\u519b\"", "label": "\"\u9648\u5411\u519b\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}, {"color": "#97c2fc", "description": "\"Cheng Jiang is a participant in the development and research of NMOSD, affiliated with Ningxia Medical University General Hospital.\"", "entity_type": "\"PERSON\"", "id": "\"\u6210\u6c5f\"", "label": "\"\u6210\u6c5f\"", "shape": "dot", "size": 10, "source_id": "chunk-3f25f31870a5e0c1064ecb45bba89ae1"}]);
                  edges = new vis.DataSet([{"description": "\"The organization is involved in the diagnosis and treatment of NMOSD, providing guidelines and standards for clinical practice.\"", "from": "\"\u4e2d\u56fd\u89c6\u795e\u7ecf\u810a\u9ad3\u708e\u8c31\u7cfb\u75be\u75c5\u8bca\u65ad\u4e0e\u6cbb\u7597\u6307\u5357\u4e2d\u56fd\u514d\u75ab\u5b66\u4f1a\u795e\u7ecf\u514d\u75ab\u5b66\u5206\u4f1a \u4e2d\u534e\u533b\u5b66\u4f1a\u795e\u7ecf\u75c5\u5b66\u5206\u4f1a\u795e\u7ecf\u514d\u75ab\u5b66\u7ec4 \u4e2d\u56fd\u533b\u5e08\u534f\u4f1a\u795e\u7ecf\u5185\u79d1\u5206\u4f1a\u795e\u7ecf\u514d\u75ab\u4e13\u4e1a\u59d4\u5458\u4f1a\"", "keywords": "\"clinical guidelines, diagnosis, treatment\"", "source_id": "chunk-d3c46123897bf67b8ac7a319f7459d5e", "to": "\"\u89c6\u795e\u7ecf\u810a\u9ad3\u708e\u8c31\u7cfb\u75be\u75c5(NEUROMYELITIS OPTICA SPECTRUM DISORDERS, NMOSD)\"", "width": 9.0}, {"description": "\"NMO is a specific form of NMOSD, and both are characterized by immune-mediated inflammatory demyelinating processes in the CNS.\"", "from": "\"\u89c6\u795e\u7ecf\u810a\u9ad3\u708e(NEUROMYELITIS OPTICA, NMO)\"", "keywords": "\"disease spectrum, clinical features\"", "source_id": "chunk-d3c46123897bf67b8ac7a319f7459d5e", "to": "\"\u89c6\u795e\u7ecf\u810a\u9ad3\u708e\u8c31\u7cfb\u75be\u75c5(NEUROMYELITIS OPTICA SPECTRUM DISORDERS, NMOSD)\"", "width": 8.0}, {"description": "\"AQP4-IgG is a highly specific marker for NMOSD, playing a crucial role in its diagnosis and pathogenesis.\"", "from": "\"\u89c6\u795e\u7ecf\u810a\u9ad3\u708e\u8c31\u7cfb\u75be\u75c5(NEUROMYELITIS OPTICA SPECTRUM DISORDERS, NMOSD)\"", "keywords": "\"diagnostic marker, pathogenesis\"", "source_id": "chunk-d3c46123897bf67b8ac7a319f7459d5e", "to": "\"AQP4-IGG (\u6c34\u901a\u9053\u86cb\u767d4\u6297\u4f53)\"", "width": 9.0}, {"description": "\"IPND developed new diagnostic criteria for NMOSD, integrating NMO into the broader NMOSD category.\"", "from": "\"\u89c6\u795e\u7ecf\u810a\u9ad3\u708e\u8c31\u7cfb\u75be\u75c5(NEUROMYELITIS OPTICA SPECTRUM DISORDERS, NMOSD)\"", "keywords": "\"diagnostic criteria, disease integration\"", "source_id": "chunk-d3c46123897bf67b8ac7a319f7459d5e", "to": "\"\u56fd\u9645NMO\u8bca\u65ad\u5c0f\u7ec4(INTERNATIONAL PANEL ON NMO DIAGNOSIS, IPND)\"", "width": 8.0}, {"description": "\"Wingerchuk and colleagues proposed the term NMOSD to encompass a broader range of related diseases in 2007.\"", "from": "\"\u89c6\u795e\u7ecf\u810a\u9ad3\u708e\u8c31\u7cfb\u75be\u75c5(NEUROMYELITIS OPTICA SPECTRUM DISORDERS, NMOSD)\"", "keywords": "\"terminology, disease classification\"", "source_id": "chunk-d3c46123897bf67b8ac7a319f7459d5e", "to": "\"WINGERCHUK\u7b49\"", "width": 7.0}, {"description": "\"NMOSD is more prevalent in non-white populations, particularly in these regions and ethnic groups.\"", "from": "\"\u89c6\u795e\u7ecf\u810a\u9ad3\u708e\u8c31\u7cfb\u75be\u75c5(NEUROMYELITIS OPTICA SPECTRUM DISORDERS, NMOSD)\"", "keywords": "\"prevalence, ethnic distribution\"", "source_id": "chunk-d3c46123897bf67b8ac7a319f7459d5e", "to": "\"\u4e9a\u6d32\u3001\u62c9\u4e01\u7f8e\u6d32\u3001\u975e\u6d32\u3001\u897f\u73ed\u7259\u88d4\u548c\u7f8e\u56fd\u539f\u4f4f\u6c11\"", "width": 8.0}, {"description": "\"These autoimmune diseases often co-occur with NMOSD, indicating a common underlying immune mechanism.\"", "from": "\"\u89c6\u795e\u7ecf\u810a\u9ad3\u708e\u8c31\u7cfb\u75be\u75c5(NEUROMYELITIS OPTICA SPECTRUM DISORDERS, NMOSD)\"", "keywords": "\"co-occurrence, immune mechanism\"", "source_id": "chunk-d3c46123897bf67b8ac7a319f7459d5e", "to": "\"\u5e72\u71e5\u7efc\u5408\u5f81\u3001\u7cfb\u7edf\u6027\u7ea2\u6591\u72fc\u75ae\u3001\u6865\u672c\u6c0f\u75c5\"", "width": 7.0}, {"description": "\"NMOSD often co-occurs with Sj\u00f6gren\u0027s Syndrome, indicating a common autoimmune basis and potential shared risk factors.\"", "from": "\"NMOSD\"", "keywords": "\"co-occurrence, autoimmune basis\"", "source_id": "chunk-8ac7464d1b9ccfb3319afbae828cc7e1", "to": "\"SJ\u00d6GREN\u0027S SYNDROME\"", "width": 8.0}, {"description": "\"NMOSD often co-occurs with Systemic Lupus Erythematosus, indicating a common autoimmune basis and potential shared risk factors.\"", "from": "\"NMOSD\"", "keywords": "\"co-occurrence, autoimmune basis\"", "source_id": "chunk-8ac7464d1b9ccfb3319afbae828cc7e1", "to": "\"SYSTEMIC LUPUS ERYTHEMATOSUS\"", "width": 8.0}, {"description": "\"NMOSD often co-occurs with Hashimoto\u0027s Disease, indicating a common autoimmune basis and potential shared risk factors.\"", "from": "\"NMOSD\"", "keywords": "\"co-occurrence, autoimmune basis\"", "source_id": "chunk-8ac7464d1b9ccfb3319afbae828cc7e1", "to": "\"HASHIMOTO\u0027S DISEASE\"", "width": 8.0}, {"description": "\"NMOSD frequently leads to Vision Impairment due to its high recurrence and disability rates.\"", "from": "\"NMOSD\"", "keywords": "\"causality, high recurrence\"", "source_id": "chunk-8ac7464d1b9ccfb3319afbae828cc7e1", "to": "\"VISION IMPAIRMENT\"", "width": 9.0}, {"description": "\"NMOSD frequently leads to Motor Function Impairment due to its high recurrence and disability rates.\"", "from": "\"NMOSD\"", "keywords": "\"causality, high recurrence\"", "source_id": "chunk-8ac7464d1b9ccfb3319afbae828cc7e1", "to": "\"MOTOR FUNCTION IMPAIRMENT\"", "width": 9.0}, {"description": "\"NMOSD frequently leads to Urinary and Bowel Dysfunction due to its high recurrence and disability rates.\"", "from": "\"NMOSD\"", "keywords": "\"causality, high recurrence\"", "source_id": "chunk-8ac7464d1b9ccfb3319afbae828cc7e1", "to": "\"URINARY AND BOWEL DYSFUNCTION\"", "width": 9.0}, {"description": "\"ON is a core clinical feature of NMOSD, often presenting as inflammation of the optic nerve.\"", "from": "\"NMOSD\"", "keywords": "\"clinical feature, diagnostic marker\"", "source_id": "chunk-d542d24224ab1496d411addcf36c956e", "to": "\"ON\"", "width": 9.0}, {"description": "\"\u6025\u6027\u810a\u9ad3\u708e is a core clinical feature of NMOSD, often presenting as inflammation of the spinal cord.\"", "from": "\"NMOSD\"", "keywords": "\"clinical feature, diagnostic marker\"", "source_id": "chunk-d542d24224ab1496d411addcf36c956e", "to": "\"\u6025\u6027\u810a\u9ad3\u708e\"", "width": 9.0}, {"description": "\"NMOSD\u7684\u4e00\u79cd\u8868\u73b0\u5f62\u5f0f\u662f\u5ef6\u9ad3\u6700\u540e\u533a\u7efc\u5408\u5f81\uff0c\u8868\u73b0\u4e3a\u987d\u56fa\u6027\u5443\u9006\u3001\u6076\u5fc3\u3001\u5455\u5410\u7b49\u3002\"\u003cSEP\u003e\"\u5ef6\u9ad3\u6700\u540e\u533a\u7efc\u5408\u5f81 is a core clinical feature of NMOSD, often affecting the medulla oblongata.\"", "from": "\"NMOSD\"", "keywords": "\"clinical feature, diagnostic marker\"\u003cSEP\u003e\"\u4e34\u5e8a\u8868\u73b0,\u75be\u75c5\u7279\u5f81\"", "source_id": "chunk-d542d24224ab1496d411addcf36c956e\u003cSEP\u003echunk-e50d60a84829b64d6b34c785f4f1153e", "to": "\"\u5ef6\u9ad3\u6700\u540e\u533a\u7efc\u5408\u5f81\"", "width": 17.0}, {"description": "\"NMO is a specific form of NMOSD characterized by lesions primarily in the optic nerve and spinal cord.\"", "from": "\"NMOSD\"", "keywords": "\"specific form, historical context\"", "source_id": "chunk-d542d24224ab1496d411addcf36c956e", "to": "\"NMO\"", "width": 8.0}, {"description": "\"r\u2010ON is a form of ON where the optic nerve is repeatedly inflamed, a clinical feature of NMOSD.\"", "from": "\"NMOSD\"", "keywords": "\"clinical feature, recurrence\"", "source_id": "chunk-d542d24224ab1496d411addcf36c956e", "to": "\"R\u2010ON\"", "width": 9.0}, {"description": "\"TM is a core clinical feature of NMOSD, often presenting as inflammation of the spinal cord.\"", "from": "\"NMOSD\"", "keywords": "\"clinical feature, diagnostic marker\"", "source_id": "chunk-d542d24224ab1496d411addcf36c956e", "to": "\"TM\"", "width": 9.0}, {"description": "\"LETM is a form of TM where the spinal cord is extensively and longitudinally inflamed, a clinical feature of NMOSD.\"", "from": "\"NMOSD\"", "keywords": "\"clinical feature, extensive inflammation\"", "source_id": "chunk-d542d24224ab1496d411addcf36c956e", "to": "\"LETM\"", "width": 9.0}, {"description": "\"r\u2010LETM is a form of LETM where the spinal cord is repeatedly and extensively inflamed, a clinical feature of NMOSD.\"", "from": "\"NMOSD\"", "keywords": "\"clinical feature, recurrence, extensive inflammation\"", "source_id": "chunk-d542d24224ab1496d411addcf36c956e", "to": "\"R\u2010LETM\"", "width": 9.0}, {"description": "\"\u4e2d\u56fd\u795e\u7ecf\u514d\u75ab\u5b66\u548c\u795e\u7ecf\u75c5\u5b66\u6742\u5fd7\u53d1\u8868\u4e86\u5173\u4e8eNMOSD\u7684\u7814\u7a76\u548c\u4e34\u5e8a\u89c2\u5bdf\uff0c\u63d0\u4f9b\u4e86\u91cd\u8981\u7684\u79d1\u5b66\u4f9d\u636e\u3002\"", "from": "\"NMOSD\"", "keywords": "\"\u5b66\u672f\u7814\u7a76,\u4e34\u5e8a\u89c2\u5bdf\"", "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e", "to": "\"\u4e2d\u56fd\u795e\u7ecf\u514d\u75ab\u5b66\u548c\u795e\u7ecf\u75c5\u5b66\u6742\u5fd7\"", "width": 9.0}, {"description": "\"NMOSD\u7684\u4e00\u79cd\u8868\u73b0\u5f62\u5f0f\u662f\u810a\u9ad3\u75c5\u53d8\uff0c\u53ef\u80fd\u4e0e\u5ef6\u9ad3\u6700\u540e\u533a\u7efc\u5408\u5f81\u76f8\u8fde\u7eed\u3002\"", "from": "\"NMOSD\"", "keywords": "\"\u4e34\u5e8a\u8868\u73b0,\u75be\u75c5\u7279\u5f81\"", "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e", "to": "\"\u810a\u9ad3\u75c5\u53d8\"", "width": 8.0}, {"description": "\"NMOSD\u7684\u4e00\u79cd\u8868\u73b0\u5f62\u5f0f\u662f\u8111\u5e72\u53ca\u7b2c\u56db\u8111\u5ba4\u5468\u8fb9\u75c7\u5019\uff0c\u8868\u73b0\u4e3a\u5934\u6655\u3001\u590d\u89c6\u3001\u5171\u6d4e\u5931\u8c03\u7b49\u3002\"", "from": "\"NMOSD\"", "keywords": "\"\u4e34\u5e8a\u8868\u73b0,\u75be\u75c5\u7279\u5f81\"", "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e", "to": "\"\u8111\u5e72\u53ca\u7b2c\u56db\u8111\u5ba4\u5468\u8fb9\u75c7\u5019\"", "width": 8.0}, {"description": "\"NMOSD\u7684\u4e00\u79cd\u8868\u73b0\u5f62\u5f0f\u662f\u4e0b\u4e18\u8111\u75c7\u5019\uff0c\u8868\u73b0\u4e3a\u56f0\u5026\u3001\u53d1\u4f5c\u6027\u7761\u75c5\u6837\u8868\u73b0\u3001\u987d\u56fa\u6027\u4f4e\u94a0\u8840\u75c7\u3001\u4f53\u6e29\u8c03\u8282\u969c\u788d\u7b49\u3002\"", "from": "\"NMOSD\"", "keywords": "\"\u4e34\u5e8a\u8868\u73b0,\u75be\u75c5\u7279\u5f81\"", "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e", "to": "\"\u4e0b\u4e18\u8111\u75c7\u5019\"", "width": 8.0}, {"description": "\"NMOSD\u7684\u4e00\u79cd\u8868\u73b0\u5f62\u5f0f\u662f\u5927\u8111\u534a\u7403\u767d\u8d28\u6216\u80fc\u80dd\u4f53\u75c7\u5019\uff0c\u8868\u73b0\u4e3a\u6de1\u6f20\u3001\u53cd\u5e94\u8fdf\u7f13\u3001\u8ba4\u77e5\u6c34\u5e73\u4e0b\u964d\u3001\u5934\u75db\u7b49\u3002\"", "from": "\"NMOSD\"", "keywords": "\"\u4e34\u5e8a\u8868\u73b0,\u75be\u75c5\u7279\u5f81\"", "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e", "to": "\"\u5927\u8111\u534a\u7403\u767d\u8d28\u6216\u80fc\u80dd\u4f53\u75c7\u5019\"", "width": 8.0}, {"description": "\"NMOSD\u7684\u67d0\u4e9b\u8868\u73b0\u5f62\u5f0f\u4e0eAQP4\u2010IgG\u9633\u6027\u76f8\u5173\uff0c\u8868\u660e\u514d\u75ab\u7cfb\u7edf\u7684\u53c2\u4e0e\u3002\"", "from": "\"NMOSD\"", "keywords": "\"\u514d\u75ab\u53cd\u5e94,\u75be\u75c5\u5173\u8054\"", "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e", "to": "\"AQP4\u2010IGG\u9633\u6027\"", "width": 7.0}, {"description": "\"NMOSD\u53ef\u80fd\u4e0e\u98ce\u6e7f\u76f8\u5173\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u5408\u5e76\u5b58\u5728\uff0c\u5982\u5e72\u71e5\u7efc\u5408\u5f81\u3001\u7cfb\u7edf\u6027\u7ea2\u6591\u72fc\u75ae\u3001\u6865\u672c\u6c0f\u75c5\u7b49\u3002\"", "from": "\"NMOSD\"", "keywords": "\"\u75be\u75c5\u5408\u5e76,\u514d\u75ab\u53cd\u5e94\"", "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e", "to": "\"\u98ce\u6e7f\u76f8\u5173\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\"", "width": 7.0}, {"description": "\"NMOSD\u53ef\u80fd\u4e0eANA\u9633\u6027\u76f8\u5173\uff0c\u8868\u660e\u514d\u75ab\u7cfb\u7edf\u7684\u53c2\u4e0e\u3002\"", "from": "\"NMOSD\"", "keywords": "\"\u514d\u75ab\u53cd\u5e94,\u75be\u75c5\u5173\u8054\"", "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e", "to": "\"ANA\"", "width": 7.0}, {"description": "\"NMOSD\u53ef\u80fd\u4e0eSSA\u9633\u6027\u76f8\u5173\uff0c\u8868\u660e\u514d\u75ab\u7cfb\u7edf\u7684\u53c2\u4e0e\u3002\"", "from": "\"NMOSD\"", "keywords": "\"\u514d\u75ab\u53cd\u5e94,\u75be\u75c5\u5173\u8054\"", "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e", "to": "\"SSA\"", "width": 7.0}, {"description": "\"NMOSD\u53ef\u80fd\u4e0eSSB\u9633\u6027\u76f8\u5173\uff0c\u8868\u660e\u514d\u75ab\u7cfb\u7edf\u7684\u53c2\u4e0e\u3002\"", "from": "\"NMOSD\"", "keywords": "\"\u514d\u75ab\u53cd\u5e94,\u75be\u75c5\u5173\u8054\"", "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e", "to": "\"SSB\"", "width": 7.0}, {"description": "\"NMOSD\u7684\u5b9e\u9a8c\u5ba4\u68c0\u67e5\u5305\u62ec\u8111\u810a\u6db2(CSF)\u5206\u6790\uff0c\u7528\u4e8e\u8bc4\u4f30\u60a3\u8005\u7684\u708e\u75c7\u548c\u514d\u75ab\u53cd\u5e94\u3002\"", "from": "\"NMOSD\"", "keywords": "\"\u5b9e\u9a8c\u5ba4\u68c0\u67e5,\u75be\u75c5\u8bca\u65ad\"", "source_id": "chunk-e50d60a84829b64d6b34c785f4f1153e", "to": "\"\u8111\u810a\u6db2(CSF)\"", "width": 8.0}, {"description": "\"Wingerchuk and others developed the 2006 diagnostic criteria for NMO, which is a specific form of NMOSD.\"", "from": "\"NMOSD\"", "keywords": "\"diagnostic criteria, research\"", "source_id": "chunk-1508a751986aeefee59f14762ad947b8", "to": "\"WINGERCHUK\"", "width": 8.0}, {"description": "\"The IPND developed the 2015 diagnostic criteria for NMOSD, which includes NMO and other related disorders.\"", "from": "\"NMOSD\"", "keywords": "\"diagnostic criteria, expert panel\"", "source_id": "chunk-1508a751986aeefee59f14762ad947b8", "to": "\"INTERNATIONAL NMO DIAGNOSIS PANEL (IPND)\"", "width": 9.0}, {"description": "\"AQP4-IgG is a key marker for diagnosing NMOSD, used to differentiate between AQP4-IgG positive and negative cases.\"", "from": "\"NMOSD\"", "keywords": "\"diagnostic marker, autoimmune response\"", "source_id": "chunk-1508a751986aeefee59f14762ad947b8", "to": "\"AQP4-IGG\"", "width": 10.0}, {"description": "\"MS is a different autoimmune disorder that needs to be excluded in the diagnosis of NMOSD.\"", "from": "\"NMOSD\"", "keywords": "\"differential diagnosis, exclusion\"", "source_id": "chunk-1508a751986aeefee59f14762ad947b8", "to": "\"MS (MULTIPLE SCLEROSIS)\"", "width": 7.0}, {"description": "\"OCT is used to measure the thickness of the retinal nerve fiber layer, which is often affected in NMOSD patients.\"", "from": "\"NMOSD\"", "keywords": "\"diagnostic tool, retinal changes\"", "source_id": "chunk-1508a751986aeefee59f14762ad947b8", "to": "\"OCT (OPTICAL COHERENCE TOMOGRAPHY)\"", "width": 8.0}, {"description": "\"Visual Evoked Potentials is a diagnostic test that measures the electrical activity in the visual pathways, often showing abnormalities in NMOSD patients.\"", "from": "\"NMOSD\"", "keywords": "\"diagnostic tool, visual pathway changes\"", "source_id": "chunk-1508a751986aeefee59f14762ad947b8", "to": "\"VISUAL EVOKED POTENTIALS\"", "width": 8.0}, {"description": "\"MRI is used to identify lesions in the spinal cord and brain, which are important for diagnosing NMOSD.\"", "from": "\"NMOSD\"", "keywords": "\"diagnostic tool, imaging\"", "source_id": "chunk-1508a751986aeefee59f14762ad947b8", "to": "\"MRI (MAGNETIC RESONANCE IMAGING)\"", "width": 9.0}, {"description": "\"Corticosteroids are a key component of the acute phase treatment for NMOSD, aimed at reducing inflammation and improving neurological function.\"", "from": "\"NMOSD\"", "keywords": "\"treatment, inflammation reduction\"", "source_id": "chunk-d760189ca87cf4816e2d4c9aaa4ad24c", "to": "\"\u7cd6\u76ae\u8d28\u6fc0\u7d20 (CORTICOSTEROIDS)\"", "width": 9.0}, {"description": "\"Methylprednisolone is used in the acute phase treatment of NMOSD to rapidly reduce inflammation and improve neurological function.\"", "from": "\"NMOSD\"", "keywords": "\"treatment, rapid response\"", "source_id": "chunk-d760189ca87cf4816e2d4c9aaa4ad24c", "to": "\"\u7532\u6cfc\u5c3c\u9f99 (METHYLPREDNISOLONE)\"", "width": 9.0}, {"description": "\"Prednisone is used in the maintenance phase of NMOSD treatment to prevent relapse and manage long-term symptoms.\"", "from": "\"NMOSD\"", "keywords": "\"treatment, long-term management\"", "source_id": "chunk-d760189ca87cf4816e2d4c9aaa4ad24c", "to": "\"\u6cfc\u5c3c\u677e (PREDNISONE)\"", "width": 8.0}, {"description": "\"Plasma exchange (PE) is a treatment method used for NMOSD, particularly in patients who do not respond well to high-dose methylprednisolone.\"", "from": "\"NMOSD\"", "keywords": "\"treatment, efficacy\"", "source_id": "chunk-c7e6004f5252810899e285bab15d921b", "to": "\"\u8840\u6d46\u7f6e\u6362 (PE)\"", "width": 8.0}, {"description": "\"Intravenous immunoglobulin (IVIg) is a treatment method used for NMOSD, particularly in patients who do not respond well to high-dose methylprednisolone.\"", "from": "\"NMOSD\"", "keywords": "\"treatment, efficacy\"", "source_id": "chunk-c7e6004f5252810899e285bab15d921b", "to": "\"\u9759\u8109\u6ce8\u5c04\u5927\u5242\u91cf\u514d\u75ab\u7403\u86cb\u767d (IVIG)\"", "width": 8.0}, {"description": "\"\u73af\u78f7\u9170\u80fa is used as a second-line drug in the treatment of NMOSD, particularly for patients who cannot undergo IVIg or PE treatment.\"\u003cSEP\u003e\"\u73af\u78f7\u9170\u80fa\u7528\u4e8e\u51cf\u5c11NMOSD\u590d\u53d1\u548c\u51cf\u7f13\u795e\u7ecf\u529f\u80fd\u969c\u788d\u8fdb\u5c55\uff0c\u4f5c\u4e3a\u4e8c\u7ebf\u836f\u7269\uff0c\u9002\u7528\u4e8e\u5176\u4ed6\u6cbb\u7597\u65e0\u6548\u7684\u60c5\u51b5\u3002\"", "from": "\"NMOSD\"", "keywords": "\"treatment, efficacy\"\u003cSEP\u003e\"treatment, second-line drug\"", "source_id": "chunk-b9071098864a619d35d144407f2b30d2\u003cSEP\u003echunk-61b576d65721d15b39a0c520f28e6ee6", "to": "\"\u73af\u78f7\u9170\u80fa\"", "width": 17.0}, {"description": "\"\u786b\u5511\u560c\u5464 is a first-line drug used to reduce recurrence and slow the progression of neurological dysfunction in NMOSD patients.\"", "from": "\"NMOSD\"", "keywords": "\"treatment, first-line drug\"", "source_id": "chunk-b9071098864a619d35d144407f2b30d2", "to": "\"\u786b\u5511\u560c\u5464\"", "width": 9.0}, {"description": "\"\u5417\u66ff\u9ea6\u8003\u915a\u916f is a first-line drug used in the treatment of NMOSD.\"\u003cSEP\u003e\"\u5417\u66ff\u9ea6\u8003\u915a\u916f\u7528\u4e8e\u51cf\u5c11NMOSD\u7684\u590d\u53d1\u548c\u51cf\u7f13\u795e\u7ecf\u529f\u80fd\u969c\u788d\u8fdb\u5c55\uff0c\u5177\u6709\u663e\u8457\u7597\u6548\u3002\"", "from": "\"NMOSD\"", "keywords": "\"treatment, efficacy\"\u003cSEP\u003e\"treatment, first-line drug\"", "source_id": "chunk-b9071098864a619d35d144407f2b30d2\u003cSEP\u003echunk-64c89732b9f2941c9331e3813eeb9803", "to": "\"\u5417\u66ff\u9ea6\u8003\u915a\u916f\"", "width": 17.0}, {"description": "\"\u7532\u6c28\u8776\u5464 can be used alone or in combination with \u6cfc\u5c3c\u677e to reduce NMOSD recurrence and functional impairment, making it a suitable option for patients who cannot tolerate other immunosuppressants.\"\u003cSEP\u003e\"\u7532\u6c28\u8776\u5464 is a first-line drug used in the treatment of NMOSD.\"", "from": "\"NMOSD\"", "keywords": "\"treatment, first-line drug\"\u003cSEP\u003e\"treatment, recurrence reduction, affordability\"", "source_id": "chunk-b9071098864a619d35d144407f2b30d2\u003cSEP\u003echunk-4729f02f7104a27cc56e83a3aba8a1a4", "to": "\"\u7532\u6c28\u8776\u5464\"", "width": 17.0}, {"description": "\"\u5229\u59a5\u6614\u5355\u6297 (rituximab) is a first-line drug used in the treatment of NMOSD.\"", "from": "\"NMOSD\"", "keywords": "\"treatment, first-line drug\"", "source_id": "chunk-b9071098864a619d35d144407f2b30d2", "to": "\"\u5229\u59a5\u6614\u5355\u6297 (RITUXIMAB)\"", "width": 8.0}, {"description": "\"\u4ed6\u514b\u83ab\u53f8 is a second-line drug used in the treatment of NMOSD.\"", "from": "\"NMOSD\"", "keywords": "\"treatment, second-line drug\"", "source_id": "chunk-b9071098864a619d35d144407f2b30d2", "to": "\"\u4ed6\u514b\u83ab\u53f8\"", "width": 8.0}, {"description": "\"\u7c73\u6258\u84bd\u918c is a second-line drug used in the treatment of NMOSD.\"\u003cSEP\u003e\"\u7c73\u6258\u84bd\u918c\u7528\u4e8e\u51cf\u5c11NMOSD\u590d\u53d1\uff0c\u4f5c\u4e3a\u4e8c\u7ebf\u836f\u7269\uff0c\u9002\u7528\u4e8e\u53cd\u590d\u53d1\u4f5c\u800c\u5176\u4ed6\u65b9\u6cd5\u6cbb\u7597\u6548\u679c\u4e0d\u4f73\u7684\u60c5\u51b5\u3002\"", "from": "\"NMOSD\"", "keywords": "\"treatment, efficacy\"\u003cSEP\u003e\"treatment, second-line drug\"", "source_id": "chunk-b9071098864a619d35d144407f2b30d2\u003cSEP\u003echunk-61b576d65721d15b39a0c520f28e6ee6", "to": "\"\u7c73\u6258\u84bd\u918c\"", "width": 17.0}, {"description": "\"IVIg is used in intermittent low doses to reduce NMOSD recurrence, but its effectiveness is based on open clinical trials, and more robust studies are needed.\"\u003cSEP\u003e\"IVIg is used in the prevention of NMOSD, particularly for patients who cannot use immunosuppressants.\"", "from": "\"NMOSD\"", "keywords": "\"treatment, prevention\"\u003cSEP\u003e\"treatment, recurrence reduction, need for further research\"", "source_id": "chunk-b9071098864a619d35d144407f2b30d2\u003cSEP\u003echunk-4729f02f7104a27cc56e83a3aba8a1a4", "to": "\"IVIG\"", "width": 15.0}, {"description": "\"PE is used in the prevention of NMOSD, particularly for patients who cannot use immunosuppressants.\"", "from": "\"NMOSD\"", "keywords": "\"treatment, prevention\"", "source_id": "chunk-b9071098864a619d35d144407f2b30d2", "to": "\"PE\"", "width": 8.0}, {"description": "\"AQP4\u2010IgG is a biomarker used to identify patients with NMOSD, particularly those who are positive for this marker.\"", "from": "\"NMOSD\"", "keywords": "\"biomarker, identification\"", "source_id": "chunk-b9071098864a619d35d144407f2b30d2", "to": "\"AQP4\u2010IGG\"", "width": 9.0}, {"description": "\"\u5355\u65f6\u76f8\u53ca\u591a\u65f6\u76f8NMOSD refers to the different phases of NMOSD, with single-phase and multi-phase types, which need to be carefully assessed.\"", "from": "\"NMOSD\"", "keywords": "\"disease type, assessment\"", "source_id": "chunk-b9071098864a619d35d144407f2b30d2", "to": "\"\u5355\u65f6\u76f8\u53ca\u591a\u65f6\u76f8NMOSD\"", "width": 8.0}, {"description": "\"\u513f\u7ae5\u53ca\u598a\u5a20\u671f\u60a3\u8005 are a specific group of patients who may require special considerations in NMOSD treatment, such as the use of IVIg.\"", "from": "\"NMOSD\"", "keywords": "\"patient group, special considerations\"", "source_id": "chunk-b9071098864a619d35d144407f2b30d2", "to": "\"\u513f\u7ae5\u53ca\u598a\u5a20\u671f\u60a3\u8005\"", "width": 8.0}, {"description": "\"\u5229\u59a5\u6614\u5355\u6297\u7528\u4e8e\u51cf\u5c11NMOSD\u7684\u590d\u53d1\u548c\u51cf\u7f13\u795e\u7ecf\u529f\u80fd\u969c\u788d\u8fdb\u5c55\uff0c\u5177\u6709\u663e\u8457\u7597\u6548\u3002\"", "from": "\"NMOSD\"", "keywords": "\"treatment, efficacy\"", "source_id": "chunk-64c89732b9f2941c9331e3813eeb9803", "to": "\"\u5229\u59a5\u6614\u5355\u6297\"", "width": 9.0}, {"description": "\"\u6cfc\u5c3c\u677e is used in low doses to maintain treatment and reduce NMOSD recurrence, often in combination with other immunosuppressants.\"", "from": "\"NMOSD\"", "keywords": "\"treatment, recurrence reduction\"", "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4", "to": "\"\u6cfc\u5c3c\u677e\"", "width": 8.0}, {"description": "\"\u73af\u5b62\u7d20A is recommended at a specific dose to reduce NMOSD recurrence, with careful monitoring for renal toxicity.\"", "from": "\"NMOSD\"", "keywords": "\"treatment, recurrence reduction, monitoring\"", "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4", "to": "\"\u73af\u5b62\u7d20A\"", "width": 8.0}, {"description": "\"\u03b2 \u5e72\u6270\u7d20, a treatment for MS, can worsen NMOSD symptoms, highlighting the need for caution in its use.\"", "from": "\"NMOSD\"", "keywords": "\"contraindication, symptom exacerbation\"", "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4", "to": "\"\u0392 \u5e72\u6270\u7d20\"", "width": 9.0}, {"description": "\"\u82ac\u6208\u83ab\u5fb7, a treatment for MS, can exacerbate NMOSD symptoms, emphasizing the need for careful selection of treatments.\"", "from": "\"NMOSD\"", "keywords": "\"contraindication, symptom exacerbation\"", "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4", "to": "\"\u82ac\u6208\u83ab\u5fb7\"", "width": 9.0}, {"description": "\"\u90a3\u4ed6\u73e0\u5355\u6297, a treatment for MS, can worsen NMOSD symptoms, underlining the importance of avoiding certain MS treatments in NMOSD patients.\"", "from": "\"NMOSD\"", "keywords": "\"contraindication, symptom exacerbation\"", "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4", "to": "\"\u90a3\u4ed6\u73e0\u5355\u6297\"", "width": 9.0}, {"description": "\"\u514d\u75ab\u6291\u5236\u5242 are used to reduce NMOSD recurrence but may have long-term risks such as increased susceptibility to infections and cancer, requiring careful consideration.\"", "from": "\"NMOSD\"", "keywords": "\"treatment, long-term risks\"", "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4", "to": "\"\u514d\u75ab\u6291\u5236\u5242\"", "width": 8.0}, {"description": "\"NMOSD patients have a similar risk of recurrence during pregnancy as non-pregnant periods, but a higher risk postpartum, necessitating continued immunosuppressive treatment.\"", "from": "\"NMOSD\"", "keywords": "\"recurrence risk, postpartum risk, treatment continuation\"", "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4", "to": "\"\u598a\u5a20\u671f\"", "width": 8.0}, {"description": "\"\u5fb7\u7ef4\u514b and his student \u9ad8\u5c14\u7279 described the initial cases of NMO, leading to the naming of Devic\u0027s disease.\"", "from": "\"\u5fb7\u7ef4\u514b\"", "keywords": "\"historical context, discovery\"", "source_id": "chunk-d542d24224ab1496d411addcf36c956e", "to": "\"NMO\"", "width": 8.0}, {"description": "\"\u9ad8\u5c14\u7279, a student of \u5fb7\u7ef4\u514b, contributed to the description of the initial cases of NMO.\"", "from": "\"\u9ad8\u5c14\u7279\"", "keywords": "\"historical context, discovery\"", "source_id": "chunk-d542d24224ab1496d411addcf36c956e", "to": "\"NMO\"", "width": 8.0}, {"description": "\"AQP4\u2010IgG is a specific biomarker for NMO, indicating a strong association between the two.\"", "from": "\"AQP4\u2010IGG\"", "keywords": "\"biomarker, disease diagnosis\"", "source_id": "chunk-3ae28088c4f039d981f2d5100cb16987", "to": "\"NEUROMYELITIS OPTICA (NMO)\"", "width": 10.0}, {"description": "\"CBA is a highly specific and sensitive method for detecting AQP4\u2010IgG, making it a preferred diagnostic tool.\"", "from": "\"AQP4\u2010IGG\"", "keywords": "\"diagnostic method, high specificity\"", "source_id": "chunk-3ae28088c4f039d981f2d5100cb16987", "to": "\"CELL-BASED TRANSFECTION IMMUNOFLUORESCENCE ASSAY (CBA)\"", "width": 9.0}, {"description": "\"ELISA is a sensitive method for detecting AQP4\u2010IgG, but it can produce false positives and has some controversy regarding its use for predicting disease progression and recurrence.\"", "from": "\"AQP4\u2010IGG\"", "keywords": "\"diagnostic method, sensitivity, controversy\"", "source_id": "chunk-3ae28088c4f039d981f2d5100cb16987", "to": "\"ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)\"", "width": 7.0}, {"description": "\"The presence of ANAs in the serum can support the diagnosis of NMOSD, indicating a potential overlap with other autoimmune conditions.\"", "from": "\"AQP4\u2010IGG\"", "keywords": "\"autoimmune markers, diagnosis support\"", "source_id": "chunk-3ae28088c4f039d981f2d5100cb16987", "to": "\"ANTI-NUCLEAR ANTIBODIES (ANAS)\"", "width": 8.0}, {"description": "\"The presence of Anti-SSA antibodies in the serum can support the diagnosis of NMOSD, indicating a potential overlap with other autoimmune conditions.\"", "from": "\"AQP4\u2010IGG\"", "keywords": "\"autoimmune markers, diagnosis support\"", "source_id": "chunk-3ae28088c4f039d981f2d5100cb16987", "to": "\"ANTI-SSA ANTIBODIES\"", "width": 8.0}, {"description": "\"The presence of Anti-SSB antibodies in the serum can support the diagnosis of NMOSD, indicating a potential overlap with other autoimmune conditions.\"", "from": "\"AQP4\u2010IGG\"", "keywords": "\"autoimmune markers, diagnosis support\"", "source_id": "chunk-3ae28088c4f039d981f2d5100cb16987", "to": "\"ANTI-SSB ANTIBODIES\"", "width": 8.0}, {"description": "\"The presence of Anti-thyroid antibodies in the serum can support the diagnosis of NMOSD, indicating a potential overlap with other autoimmune conditions.\"", "from": "\"AQP4\u2010IGG\"", "keywords": "\"autoimmune markers, diagnosis support\"", "source_id": "chunk-3ae28088c4f039d981f2d5100cb16987", "to": "\"ANTI-THYROID ANTIBODIES\"", "width": 8.0}, {"description": "\"MOG antibodies are found in a significant portion of AQP4\u2010IgG negative NMOSD patients, indicating a different clinical presentation and course.\"", "from": "\"AQP4\u2010IGG\"", "keywords": "\"alternative biomarker, clinical presentation\"", "source_id": "chunk-3ae28088c4f039d981f2d5100cb16987", "to": "\"MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG) ANTIBODIES\"", "width": 9.0}, {"description": "\"N-Methyl-D-Aspartate Receptor Antibodies can be present in patients with NMOSD, particularly in those with tumors, indicating a complex relationship.\"", "from": "\"AQP4\u2010IGG\"", "keywords": "\"autoimmune markers, complex conditions\"", "source_id": "chunk-3ae28088c4f039d981f2d5100cb16987", "to": "\"N-METHYL-D-ASPARTATE RECEPTOR ANTIBODIES\"", "width": 7.0}, {"description": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\u5f3a\u8c03\u4e86AQP4-IgG\u7684\u8bca\u65ad\u7279\u5f02\u6027\uff0c\u4f46\u4ecd\u7136\u5b58\u5728\u5047\u9633\u6027\u548c\u5047\u9634\u6027\u7684\u60c5\u51b5\u3002\"", "from": "\"AQP4-IGG\"", "keywords": "\"diagnostic marker, specificity, sensitivity\"", "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea", "to": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\"", "width": 9.0}, {"description": "\"2006\u5e74NMO\u8bca\u65ad\u6807\u51c6\u548c2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\u90fd\u5b58\u5728\u8bca\u65ad\u7279\u5f02\u5ea6\u53ca\u654f\u611f\u5ea6\u95ee\u9898\uff0c\u4f462015\u5e74\u6807\u51c6\u66f4\u5f3a\u8c03AQP4-IgG\u7684\u8bca\u65ad\u7279\u5f02\u6027\u3002\"", "from": "\"2006\u5e74NMO\u8bca\u65ad\u6807\u51c6\"", "keywords": "\"diagnostic criteria, specificity, sensitivity\"", "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea", "to": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\"", "width": 8.0}, {"description": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\u9700\u8981\u4e0e\u591a\u53d1\u6027\u786c\u5316\u75c7\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "from": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\"", "keywords": "\"differential diagnosis, inflammatory demyelinating diseases\"", "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea", "to": "\"MS(\u591a\u53d1\u6027\u786c\u5316\u75c7)\"", "width": 7.0}, {"description": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\u9700\u8981\u4e0e\u6025\u6027\u64ad\u6563\u6027\u8111\u810a\u9ad3\u708e\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "from": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\"", "keywords": "\"differential diagnosis, inflammatory demyelinating diseases\"", "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea", "to": "\"\u6025\u6027\u64ad\u6563\u6027\u8111\u810a\u9ad3\u708e\"", "width": 7.0}, {"description": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\u9700\u8981\u4e0e\u5047\u7624\u578b\u8131\u9ad3\u9798\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "from": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\"", "keywords": "\"differential diagnosis, inflammatory demyelinating diseases\"", "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea", "to": "\"\u5047\u7624\u578b\u8131\u9ad3\u9798\"", "width": 7.0}, {"description": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\u9700\u8981\u4e0e\u7cfb\u7edf\u6027\u7ea2\u6591\u72fc\u75ae\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "from": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\"", "keywords": "\"differential diagnosis, systemic diseases\"", "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea", "to": "\"\u7cfb\u7edf\u6027\u7ea2\u6591\u72fc\u75ae\"", "width": 7.0}, {"description": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\u9700\u8981\u4e0e\u767d\u585e\u75c5\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "from": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\"", "keywords": "\"differential diagnosis, systemic diseases\"", "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea", "to": "\"\u767d\u585e\u75c5\"", "width": 7.0}, {"description": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\u9700\u8981\u4e0e\u5e72\u71e5\u7efc\u5408\u5f81\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "from": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\"", "keywords": "\"differential diagnosis, systemic diseases\"", "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea", "to": "\"\u5e72\u71e5\u7efc\u5408\u5f81\"", "width": 7.0}, {"description": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\u9700\u8981\u4e0e\u7ed3\u8282\u75c5\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "from": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\"", "keywords": "\"differential diagnosis, systemic diseases\"", "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea", "to": "\"\u7ed3\u8282\u75c5\"", "width": 7.0}, {"description": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\u9700\u8981\u4e0e\u7cfb\u7edf\u6027\u8840\u7ba1\u708e\u8fdb\u884c\u9274\u522b\u8bca\u65ad\u3002\"", "from": "\"2015\u5e74NMOSD\u8bca\u65ad\u6807\u51c6\"", "keywords": "\"differential diagnosis, systemic diseases\"", "source_id": "chunk-986f5e5e25af5fc5cd7f1b02d15e67ea", "to": "\"\u7cfb\u7edf\u6027\u8840\u7ba1\u708e\"", "width": 7.0}, {"description": "\"Methylprednisolone is a specific corticosteroid used in the high-dose intravenous phase of NMOSD treatment.\"", "from": "\"\u7cd6\u76ae\u8d28\u6fc0\u7d20 (CORTICOSTEROIDS)\"", "keywords": "\"specific drug, high-dose treatment\"", "source_id": "chunk-d760189ca87cf4816e2d4c9aaa4ad24c", "to": "\"\u7532\u6cfc\u5c3c\u9f99 (METHYLPREDNISOLONE)\"", "width": 8.0}, {"description": "\"Prednisone is a specific corticosteroid used in the oral maintenance phase of NMOSD treatment.\"", "from": "\"\u7cd6\u76ae\u8d28\u6fc0\u7d20 (CORTICOSTEROIDS)\"", "keywords": "\"specific drug, maintenance treatment\"", "source_id": "chunk-d760189ca87cf4816e2d4c9aaa4ad24c", "to": "\"\u6cfc\u5c3c\u677e (PREDNISONE)\"", "width": 8.0}, {"description": "\"Corticosteroids and immunosuppressants are often used in combination to manage NMOSD, with immunosuppressants preventing relapse and managing long-term symptoms.\"", "from": "\"\u7cd6\u76ae\u8d28\u6fc0\u7d20 (CORTICOSTEROIDS)\"", "keywords": "\"combination therapy, relapse prevention\"", "source_id": "chunk-d760189ca87cf4816e2d4c9aaa4ad24c", "to": "\"\u514d\u75ab\u6291\u5236\u5242 (IMMUNOSUPPRESSANTS)\"", "width": 9.0}, {"description": "\"High-dose hormone therapy can cause arrhythmia, requiring careful monitoring and management.\"", "from": "\"\u5927\u5242\u91cf\u6fc0\u7d20\u6cbb\u7597\"", "keywords": "\"side effect, monitoring\"", "source_id": "chunk-c7e6004f5252810899e285bab15d921b", "to": "\"\u5fc3\u5f8b\u5931\u5e38\"", "width": 8.0}, {"description": "\"Proton pump inhibitors are used to prevent upper gastrointestinal bleeding, a common side effect of high-dose hormone therapy.\"", "from": "\"\u5927\u5242\u91cf\u6fc0\u7d20\u6cbb\u7597\"", "keywords": "\"side effect, prevention\"", "source_id": "chunk-c7e6004f5252810899e285bab15d921b", "to": "\"\u8d28\u5b50\u6cf5\u6291\u5236\u5242\"", "width": 7.0}, {"description": "\"Stroke prevention is recommended for older patients or those with stroke risk factors during high-dose hormone therapy.\"", "from": "\"\u5927\u5242\u91cf\u6fc0\u7d20\u6cbb\u7597\"", "keywords": "\"side effect, prevention\"", "source_id": "chunk-c7e6004f5252810899e285bab15d921b", "to": "\"\u5352\u4e2d\u9884\u9632\"", "width": 6.0}, {"description": "\"Electrolyte imbalance is a common side effect of high-dose hormone therapy.\"", "from": "\"\u5927\u5242\u91cf\u6fc0\u7d20\u6cbb\u7597\"", "keywords": "\"side effect, management\"", "source_id": "chunk-c7e6004f5252810899e285bab15d921b", "to": "\"\u7535\u89e3\u8d28\u7d0a\u4e71\"", "width": 7.0}, {"description": "\"Abnormal blood sugar, blood pressure, and lipid levels are common side effects of high-dose hormone therapy.\"", "from": "\"\u5927\u5242\u91cf\u6fc0\u7d20\u6cbb\u7597\"", "keywords": "\"side effect, management\"", "source_id": "chunk-c7e6004f5252810899e285bab15d921b", "to": "\"\u8840\u7cd6\u3001\u8840\u538b\u3001\u8840\u8102\u5f02\u5e38\"", "width": 7.0}, {"description": "\"Upper gastrointestinal bleeding is a common side effect of high-dose hormone therapy.\"", "from": "\"\u5927\u5242\u91cf\u6fc0\u7d20\u6cbb\u7597\"", "keywords": "\"side effect, prevention\"", "source_id": "chunk-c7e6004f5252810899e285bab15d921b", "to": "\"\u4e0a\u6d88\u5316\u9053\u51fa\u8840\"", "width": 7.0}, {"description": "\"Osteoporosis and avascular necrosis of the femoral head are potential complications of long-term high-dose hormone therapy.\"", "from": "\"\u5927\u5242\u91cf\u6fc0\u7d20\u6cbb\u7597\"", "keywords": "\"side effect, prevention\"", "source_id": "chunk-c7e6004f5252810899e285bab15d921b", "to": "\"\u9aa8\u8d28\u758f\u677e\u3001\u80a1\u9aa8\u5934\u574f\u6b7b\"", "width": 6.0}, {"description": "\"\u7f8e\u53f8\u94a0 (Uromitexan) \u7528\u4e8e\u9884\u9632\u73af\u78f7\u9170\u80fa\u5f15\u8d77\u7684\u51fa\u8840\u6027\u8180\u80f1\u708e\u3002\"", "from": "\"\u73af\u78f7\u9170\u80fa\"", "keywords": "\"preventive measure, side effect management\"", "source_id": "chunk-61b576d65721d15b39a0c520f28e6ee6", "to": "\"\u7f8e\u53f8\u94a0 (UROMITEXAN)\"", "width": 8.0}, {"description": "\"\u73af\u78f7\u9170\u80fa\u4e0d\u63a8\u8350\u5728\u598a\u5a20\u524d\u671f\u3001\u598a\u5a20\u548c\u54fa\u4e73\u671f\u4f7f\u7528\uff0c\u9664\u975e\u5b55\u5987\u5177\u6709\u751f\u547d\u5371\u9669\u6216\u5668\u5b98\u529f\u80fd\u8870\u7aed\u98ce\u9669\u3002\"", "from": "\"\u73af\u78f7\u9170\u80fa\"", "keywords": "\"\u7981\u5fcc,\u98ce\u9669\"", "source_id": "chunk-08e2af106947799f5d0790038b946347", "to": "\"\u598a\u5a20\u671f\"", "width": 6.0}, {"description": "\"\u786b\u4ee3\u560c\u5464\u7532\u57fa\u8f6c\u79fb\u9176 (TMTP) is tested to avoid severe adverse reactions to\u786b\u5511\u560c\u5464.\"", "from": "\"\u786b\u5511\u560c\u5464\"", "keywords": "\"enzyme, adverse reaction prevention\"", "source_id": "chunk-b9071098864a619d35d144407f2b30d2", "to": "\"\u786b\u4ee3\u560c\u5464\u7532\u57fa\u8f6c\u79fb\u9176 (TMTP)\"", "width": 9.0}, {"description": "\"\u5417\u66ff\u9ea6\u8003\u915a\u916f\u8d77\u6548\u8f83\u786b\u5511\u560c\u5464\u5feb\uff0c\u526f\u4f5c\u7528\u8f83\u5c11\u3002\"", "from": "\"\u786b\u5511\u560c\u5464\"", "keywords": "\"comparison, side effects\"", "source_id": "chunk-64c89732b9f2941c9331e3813eeb9803", "to": "\"\u5417\u66ff\u9ea6\u8003\u915a\u916f\"", "width": 8.0}, {"description": "\"\u786b\u5511\u560c\u5464\u5728\u598a\u5a20\u671f\u4f7f\u7528\u5177\u6709B\u7ea7\u63a8\u8350\uff0c\u5242\u91cf\u9700\u22642mg/(kg\u30fbd)\uff0c\u8868\u660e\u5176\u5728\u598a\u5a20\u671f\u7684\u4f7f\u7528\u6761\u4ef6\u3002\"", "from": "\"\u786b\u5511\u560c\u5464\"", "keywords": "\"\u5242\u91cf\u9650\u5236,\u5b89\u5168\u6027\"", "source_id": "chunk-08e2af106947799f5d0790038b946347", "to": "\"\u598a\u5a20\u671f\"", "width": 8.0}, {"description": "\"\u7532\u6c28\u8776\u5464\u5728\u598a\u5a20\u671f\u5e94\u907f\u514d\u4f7f\u7528\uff0c\u53d7\u5b55\u524d3\u4e2a\u6708\u5e94\u505c\u7528\uff0c\u54fa\u4e73\u671f\u4e0d\u63a8\u8350\u4f7f\u7528\u3002\"", "from": "\"\u7532\u6c28\u8776\u5464\"", "keywords": "\"\u7981\u5fcc,\u98ce\u9669\"", "source_id": "chunk-08e2af106947799f5d0790038b946347", "to": "\"\u598a\u5a20\u671f\"", "width": 6.0}, {"description": "\"\u4ed6\u514b\u83ab\u53f8\u5728\u598a\u5a20\u671f\u4f7f\u7528\u6700\u4f4e\u6709\u6548\u5242\u91cf\uff0c\u5177\u6709D\u7ea7\u63a8\u8350\uff0c\u8868\u660e\u5176\u5728\u598a\u5a20\u671f\u7684\u4f7f\u7528\u6761\u4ef6\u3002\"", "from": "\"\u4ed6\u514b\u83ab\u53f8\"", "keywords": "\"\u5242\u91cf\u9650\u5236,\u5b89\u5168\u6027\"", "source_id": "chunk-08e2af106947799f5d0790038b946347", "to": "\"\u598a\u5a20\u671f\"", "width": 7.0}, {"description": "\"\u5229\u59a5\u6614\u5355\u6297\u901a\u8fc7\u6d88\u51cfB\u7ec6\u80de\u6765\u51cf\u5c11NMOSD\u7684\u590d\u53d1\u548c\u51cf\u7f13\u795e\u7ecf\u529f\u80fd\u969c\u788d\u8fdb\u5c55\u3002\"", "from": "\"\u5229\u59a5\u6614\u5355\u6297\"", "keywords": "\"treatment mechanism, immune response\"", "source_id": "chunk-64c89732b9f2941c9331e3813eeb9803", "to": "\"B\u7ec6\u80de\"", "width": 9.0}, {"description": "\"\u6709\u6587\u732e\u62a5\u9053\u5728\u4f7f\u7528\u5229\u59a5\u6614\u5355\u6297\u6cbb\u7597\u80bf\u7624\u6216\u7c7b\u98ce\u6e7f\u5173\u8282\u708e\u65f6\u53d1\u751f\u8fdb\u884c\u6027\u591a\u7076\u6027\u767d\u8d28\u8111\u75c5\uff0c\u4f46\u5927\u591a\u6570\u75c5\u4f8b\u5408\u7528\u4e86\u5176\u4ed6\u514d\u75ab\u6291\u5236\u5242\u3002\"", "from": "\"\u5229\u59a5\u6614\u5355\u6297\"", "keywords": "\"side effects, risk\"", "source_id": "chunk-64c89732b9f2941c9331e3813eeb9803", "to": "\"\u8fdb\u884c\u6027\u591a\u7076\u6027\u767d\u8d28\u8111\u75c5\"", "width": 7.0}, {"description": "\"\u5229\u59a5\u6614\u5355\u6297\u4e0d\u5efa\u8bae\u5728\u598a\u5a20\u524d\u671f\u3001\u598a\u5a20\u548c\u54fa\u4e73\u671f\u4f7f\u7528\uff0c\u56e0\u4e3a\u80ce\u513f\u7684\u5b89\u5168\u6027\u6587\u732e\u4e0d\u8db3\uff0c\u7406\u8bba\u4e0a\u5b58\u5728\u98ce\u9669\u3002\"", "from": "\"\u5229\u59a5\u6614\u5355\u6297\"", "keywords": "\"\u7981\u5fcc,\u98ce\u9669\"", "source_id": "chunk-08e2af106947799f5d0790038b946347", "to": "\"\u598a\u5a20\u671f\"", "width": 6.0}, {"description": "\"\u73af\u5b62\u7d20A\u5728\u598a\u5a20\u671f\u4f7f\u7528\u6700\u4f4e\u6709\u6548\u5242\u91cf\uff0c\u5177\u6709B\u7ea7\u63a8\u8350\uff0c\u8868\u660e\u5176\u5728\u598a\u5a20\u671f\u7684\u4f7f\u7528\u6761\u4ef6\u3002\"", "from": "\"\u73af\u5b62\u7d20A\"", "keywords": "\"\u5242\u91cf\u9650\u5236,\u5b89\u5168\u6027\"", "source_id": "chunk-08e2af106947799f5d0790038b946347", "to": "\"\u598a\u5a20\u671f\"", "width": 8.0}, {"description": "\"The use of immunosuppressants in reproductive age patients, both male and female, can have significant risks for the fetus or newborn, requiring careful management.\"", "from": "\"\u514d\u75ab\u6291\u5236\u5242\"", "keywords": "\"reproductive risks, fetal safety, treatment management\"", "source_id": "chunk-4729f02f7104a27cc56e83a3aba8a1a4", "to": "\"\u751f\u80b2\u671f\"", "width": 9.0}, {"description": "\"IVIg (\u4e19\u79cd\u7403\u86cb\u767d)\u5728\u598a\u5a20\u671f\u4f7f\u7528\u5177\u6709A\u7ea7\u63a8\u8350\uff0c\u8868\u660e\u5176\u5728\u598a\u5a20\u671f\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002\"", "from": "\"\u598a\u5a20\u671f\"", "keywords": "\"\u5b89\u5168\u6027,\u6709\u6548\u6027\"", "source_id": "chunk-08e2af106947799f5d0790038b946347", "to": "\"IVIG (\u4e19\u79cd\u7403\u86cb\u767d)\"", "width": 9.0}, {"description": "\"\u9ea6\u8003\u915a\u9178\u916f\u7981\u5fcc\u5728\u598a\u5a20\u671f\u95f4\u4f7f\u7528\uff0c\u8ba1\u5212\u6000\u5b55\u524d\u81f3\u5c116\u5468\u5e94\u505c\u7528\uff0c\u54fa\u4e73\u671f\u4e0d\u5efa\u8bae\u4f7f\u7528\u3002\"", "from": "\"\u598a\u5a20\u671f\"", "keywords": "\"\u7981\u5fcc,\u98ce\u9669\"", "source_id": "chunk-08e2af106947799f5d0790038b946347", "to": "\"\u9ea6\u8003\u915a\u9178\u916f\"", "width": 6.0}, {"description": "\"\u7532\u6cfc\u5c3c\u677e\u9f99\u7684\u80ce\u76d8\u8f6c\u8fd0\u7387\u4e0e\u6cfc\u5c3c\u677e\u9f99\u76f8\u4f3c\uff0c\u4ea7\u751f\u7b49\u6548\u6297\u708e\u4f5c\u7528\u6240\u9700\u5242\u91cf\u4e3a\u6cfc\u5c3c\u677e\u9f99\u768480%\uff0c\u56e0\u6b64\u5728\u598a\u5a20\u548c\u54fa\u4e73\u671f\u5747\u53ef\u4f7f\u7528\u3002\"", "from": "\"\u6cfc\u5c3c\u677e\u9f99\"", "keywords": "\"\u76f8\u4f3c\u6027,\u5242\u91cf\u5dee\u5f02\"", "source_id": "chunk-08e2af106947799f5d0790038b946347", "to": "\"\u7532\u6cfc\u5c3c\u677e\u9f99\"", "width": 8.0}, {"description": "\"\u5df4\u6c2f\u82ac\u7528\u4e8e\u6cbb\u7597\u75db\u6027\u75c9\u631b\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u5df4\u6c2f\u82ac\"", "keywords": "\"treatment, pain management\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"\u75db\u6027\u75c9\u631b\"", "width": 9.0}, {"description": "\"\u5df4\u6c2f\u82ac\u7528\u4e8e\u6cbb\u7597\u987d\u56fa\u6027\u5443\u9006\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u5df4\u6c2f\u82ac\"", "keywords": "\"treatment, symptom management\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"\u987d\u56fa\u6027\u5443\u9006\"", "width": 9.0}, {"description": "\"\u963f\u7c73\u66ff\u6797\u7528\u4e8e\u6cbb\u7597\u6162\u6027\u75bc\u75db\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u963f\u7c73\u66ff\u6797\"", "keywords": "\"treatment, pain management\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"\u6162\u6027\u75bc\u75db\"", "width": 9.0}, {"description": "\"\u963f\u7c73\u66ff\u6797\u7528\u4e8e\u6cbb\u7597\u611f\u89c9\u5f02\u5e38\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u963f\u7c73\u66ff\u6797\"", "keywords": "\"treatment, symptom management\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"\u611f\u89c9\u5f02\u5e38\"", "width": 9.0}, {"description": "\"\u83ab\u8fbe\u975e\u5c3c\u7528\u4e8e\u6cbb\u7597\u4e4f\u529b\u548c\u75b2\u52b3\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u83ab\u8fbe\u975e\u5c3c (MODAFINIL)\"", "keywords": "\"treatment, fatigue management\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"\u4e4f\u529b\u3001\u75b2\u52b3\"", "width": 9.0}, {"description": "\"\u91d1\u521a\u70f7\u80fa\u7528\u4e8e\u6cbb\u7597\u4e4f\u529b\u548c\u75b2\u52b3\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u91d1\u521a\u70f7\u80fa\"", "keywords": "\"treatment, fatigue management\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"\u4e4f\u529b\u3001\u75b2\u52b3\"", "width": 9.0}, {"description": "\"\u76d0\u9178\u82ef\u6d77\u7d22\u7528\u4e8e\u6cbb\u7597\u9707\u98a4\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u76d0\u9178\u82ef\u6d77\u7d22\"", "keywords": "\"treatment, tremor management\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"\u9707\u98a4\"", "width": 9.0}, {"description": "\"\u76d0\u9178\u963f\u7f57\u6d1b\u5c14\u7528\u4e8e\u6cbb\u7597\u9707\u98a4\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u76d0\u9178\u963f\u7f57\u6d1b\u5c14\"", "keywords": "\"treatment, tremor management\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"\u9707\u98a4\"", "width": 9.0}, {"description": "\"\u4e19\u54aa\u55ea\u7528\u4e8e\u6cbb\u7597\u5c3f\u5931\u7981\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u4e19\u54aa\u55ea\"", "keywords": "\"treatment, urinary incontinence\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"\u5c3f\u5931\u7981\"", "width": 9.0}, {"description": "\"\u5965\u6614\u5e03\u5b81\u7528\u4e8e\u6cbb\u7597\u5c3f\u5931\u7981\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u5965\u6614\u5e03\u5b81\"", "keywords": "\"treatment, urinary incontinence\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"\u5c3f\u5931\u7981\"", "width": 9.0}, {"description": "\"\u54cc\u5511\u55ea\u7528\u4e8e\u6cbb\u7597\u5c3f\u5931\u7981\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u54cc\u5511\u55ea\"", "keywords": "\"treatment, urinary incontinence\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"\u5c3f\u5931\u7981\"", "width": 9.0}, {"description": "\"\u76d0\u9178\u5766\u7d22\u7f57\u8f9b\u7528\u4e8e\u6cbb\u7597\u5c3f\u5931\u7981\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u76d0\u9178\u5766\u7d22\u7f57\u8f9b\"", "keywords": "\"treatment, urinary incontinence\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"\u5c3f\u5931\u7981\"", "width": 9.0}, {"description": "\"\u7f13\u6cfb\u836f\u7528\u4e8e\u6cbb\u7597\u4fbf\u79d8\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u7f13\u6cfb\u836f\"", "keywords": "\"treatment, constipation management\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"\u4fbf\u79d8\"", "width": 9.0}, {"description": "\"\u8089\u6bd2\u6bd2\u7d20A\u7528\u4e8e\u6cbb\u7597\u4e0b\u80a2\u75c9\u631b\u6027\u808c\u5f20\u529b\u589e\u9ad8\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u8089\u6bd2\u6bd2\u7d20A\"", "keywords": "\"treatment, muscle spasticity\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"\u4e0b\u80a2\u75c9\u631b\u6027\u808c\u5f20\u529b\u589e\u9ad8\"", "width": 9.0}, {"description": "\"\u80c6\u78b1\u916f\u9176\u6291\u5236\u5242\u7528\u4e8e\u6cbb\u7597\u8ba4\u77e5\u969c\u788d\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u80c6\u78b1\u916f\u9176\u6291\u5236\u5242\"", "keywords": "\"treatment, cognitive impairment\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"\u8ba4\u77e5\u969c\u788d\"", "width": 9.0}, {"description": "\"\u4e13\u4e1a\u533b\u751f\u6307\u5bfc\u60a3\u8005\u8fdb\u884cNMOSD\u7684\u5eb7\u590d\u6cbb\u7597\uff0c\u786e\u4fdd\u6cbb\u7597\u7684\u6709\u6548\u6027\u3002\"", "from": "\"NMOSD\u7684\u5eb7\u590d\u6cbb\u7597\"", "keywords": "\"medical guidance, rehabilitation\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"\u4e13\u4e1a\u533b\u751f\"", "width": 9.0}, {"description": "\"SSRI\u7528\u4e8e\u6cbb\u7597\u6162\u6027\u75bc\u75db\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u6162\u6027\u75bc\u75db\"", "keywords": "\"treatment, pain management\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"SSRI\"", "width": 9.0}, {"description": "\"SNRI\u7528\u4e8e\u6cbb\u7597\u6162\u6027\u75bc\u75db\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u6162\u6027\u75bc\u75db\"", "keywords": "\"treatment, pain management\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"SNRI\"", "width": 9.0}, {"description": "\"NaSSA\u7528\u4e8e\u6cbb\u7597\u6162\u6027\u75bc\u75db\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u6162\u6027\u75bc\u75db\"", "keywords": "\"treatment, pain management\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"NASSA\"", "width": 9.0}, {"description": "\"SSRI\u7528\u4e8e\u6cbb\u7597\u611f\u89c9\u5f02\u5e38\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u611f\u89c9\u5f02\u5e38\"", "keywords": "\"treatment, symptom management\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"SSRI\"", "width": 9.0}, {"description": "\"SNRI\u7528\u4e8e\u6cbb\u7597\u611f\u89c9\u5f02\u5e38\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u611f\u89c9\u5f02\u5e38\"", "keywords": "\"treatment, symptom management\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"SNRI\"", "width": 9.0}, {"description": "\"NaSSA\u7528\u4e8e\u6cbb\u7597\u611f\u89c9\u5f02\u5e38\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u611f\u89c9\u5f02\u5e38\"", "keywords": "\"treatment, symptom management\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"NASSA\"", "width": 9.0}, {"description": "\"SSRI\u7528\u4e8e\u6cbb\u7597\u6291\u90c1\u7126\u8651\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"SSRI\"", "keywords": "\"treatment, mental health\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"\u6291\u90c1\u7126\u8651\"", "width": 9.0}, {"description": "\"SNRI\u7528\u4e8e\u6cbb\u7597\u6291\u90c1\u7126\u8651\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u6291\u90c1\u7126\u8651\"", "keywords": "\"treatment, mental health\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"SNRI\"", "width": 9.0}, {"description": "\"NaSSA\u7528\u4e8e\u6cbb\u7597\u6291\u90c1\u7126\u8651\uff0c\u662f\u8be5\u75c7\u72b6\u7684\u5e38\u7528\u836f\u7269\u3002\"", "from": "\"\u6291\u90c1\u7126\u8651\"", "keywords": "\"treatment, mental health\"", "source_id": "chunk-1566cfb7c4ce2f6905effb75f79ec360", "to": "\"NASSA\"", "width": 9.0}]);

                  nodeColors = {};
                  allNodes = nodes.get({ returnType: "Object" });
                  for (nodeId in allNodes) {
                    nodeColors[nodeId] = allNodes[nodeId].color;
                  }
                  allEdges = edges.get({ returnType: "Object" });
                  // adding nodes and edges to the graph
                  data = {nodes: nodes, edges: edges};

                  var options = {
    "configure": {
        "enabled": false
    },
    "edges": {
        "color": {
            "inherit": true
        },
        "smooth": {
            "enabled": true,
            "type": "dynamic"
        }
    },
    "interaction": {
        "dragNodes": true,
        "hideEdgesOnDrag": false,
        "hideNodesOnDrag": false
    },
    "physics": {
        "enabled": true,
        "stabilization": {
            "enabled": true,
            "fit": true,
            "iterations": 1000,
            "onlyDynamicEdges": false,
            "updateInterval": 50
        }
    }
};

                  


                  

                  network = new vis.Network(container, data, options);

                  

                  

                  


                  
                      network.on("stabilizationProgress", function(params) {
                          document.getElementById('loadingBar').removeAttribute("style");
                          var maxWidth = 496;
                          var minWidth = 20;
                          var widthFactor = params.iterations/params.total;
                          var width = Math.max(minWidth,maxWidth * widthFactor);
                          document.getElementById('bar').style.width = width + 'px';
                          document.getElementById('text').innerHTML = Math.round(widthFactor*100) + '%';
                      });
                      network.once("stabilizationIterationsDone", function() {
                          document.getElementById('text').innerHTML = '100%';
                          document.getElementById('bar').style.width = '496px';
                          document.getElementById('loadingBar').style.opacity = 0;
                          // really clean the dom element
                          setTimeout(function () {document.getElementById('loadingBar').style.display = 'none';}, 500);
                      });
                  

                  return network;

              }
              drawGraph();
        </script>
    </body>
</html>